[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 3648
1. Vallejo Casas JA, Pérez Varo MC, Moreno Ortega E, Contreras Puertas PI, García Guerrero JC, Latre Romero JM: [99mTc-HMPAO leukocytes: doughnut image due to adenocarcinoma of colon]. Rev Esp Med Nucl; 2006 Jan-Feb;25(1):41

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [99mTc-HMPAO leukocytes: doughnut image due to adenocarcinoma of colon].
  • [Transliterated title] 99mTc-HMPAO leucocitos: imagen ''donuts'' por adenocarcinoma metastásico.
  • [MeSH-major] Adenocarcinoma, Mucinous / radionuclide imaging. Colonic Neoplasms / radionuclide imaging. Radiopharmaceuticals. Technetium Tc 99m Exametazime

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16540012.001).
  • [ISSN] 0212-6982
  • [Journal-full-title] Revista española de medicina nuclear
  • [ISO-abbreviation] Rev Esp Med Nucl
  • [Language] spa
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 3B744AG22N / Technetium Tc 99m Exametazime
  •  go-up   go-down


2. Zamir N, Ahmed S, Akhtar J: Mucinous adenocarcinoma of colon. APSP J Case Rep; 2010 Jul;1(2):20

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mucinous adenocarcinoma of colon.
  • We report two cases of mucinous adenocarcinoma of colon, one in a 9 years old male and other in a female of 12 years.
  • He had mucinous adenocarcinoma (T3N0MX) of rectosigmoid region and underwent local complete resection of the tumor with colostomy.
  • The girl presented with signs of intestinal obstruction and at colonoscopy a stricture found in descending colon.
  • The tumor was resected and biopsy reported as poorly differentiated mucinous adenocarcinoma with positive mesenteric nodes positive for tumor (T3N2MX).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Postgrad Med. 1993 Oct-Dec;39(4):218-9 [7527858.001]
  • [Cites] J Pediatr Surg. 1999 Oct;34(10):1499-504 [10549756.001]
  • [Cites] Indian Pediatr. 2001 Aug;38(8):933-4 [11521016.001]
  • [Cites] Paediatr Drugs. 2008;10(3):177-92 [18454570.001]
  • [Cites] Indian J Cancer. 2008 Jul-Sep;45(3):119-22 [19018116.001]
  • [Cites] Afr J Paediatr Surg. 2009 Jan-Jun;6(1):65-7 [19661674.001]
  • [Cites] J Clin Oncol. 2007 Dec 20;25(36):5808-14 [18089879.001]
  • [Cites] J Ayub Med Coll Abbottabad. 2007 Jul-Sep;19(3):56-63 [18444593.001]
  • (PMID = 22953263.001).
  • [ISSN] 2218-8185
  • [Journal-full-title] APSP journal of case reports
  • [ISO-abbreviation] APSP J Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Pakistan
  • [Other-IDs] NLM/ PMC3417995
  • [Keywords] NOTNLM ; Bleeding per rectum / Child / Mucinous adenocarcinoma / Colorectum
  •  go-up   go-down


3. Accioly MT, Pacheco P, Maya-Monteiro CM, Carrossini N, Robbs BK, Oliveira SS, Kaufmann C, Morgado-Diaz JA, Bozza PT, Viola JP: Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells. Cancer Res; 2008 Mar 15;68(6):1732-40
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells.
  • Increased lipid body numbers have been described in tumor cells; however, its functional significance in cancer has never been addressed.
  • Here, we showed increased number of lipid bodies in tumor tissues from patients with adenocarcinoma of colon submitted to surgical resection when compared with an adjacent normal tissue.
  • Accordingly, increased numbers of lipid bodies were observed in human colon adenocarcinoma cell lines and in a H-rasV12-transformed intestinal epithelial cell line (IEC-6 H-rasV12) compared with nontransformed IEC-6 cells.
  • The functions of lipid bodies in eicosanoid synthesis in cancer cells were investigated.
  • Direct localization of PGE(2) at its synthesis locale showed that lipid bodies are sources of eicosanoids in the transformed colon cancer cells.
  • Together, our results showed that lipid bodies in colon cancer cells are dynamic and functional active organelles centrally involved in PGE(2) synthesis and may potentially have implications in the pathogenesis of adenocarcinoma of colon.
  • [MeSH-major] Adenocarcinoma / metabolism. Colonic Neoplasms / metabolism. Cyclooxygenase 2 / metabolism. Dinoprostone / biosynthesis. Lipid Metabolism. Organelles / metabolism

  • Hazardous Substances Data Bank. ACETYLSALICYLIC ACID .
  • Hazardous Substances Data Bank. BUTYROLACTONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18339853.001).
  • [ISSN] 1538-7445
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid; EC 1.14.99.1 / Cyclooxygenase 2; K7Q1JQR04M / Dinoprostone; OL659KIY4X / 4-Butyrolactone; R16CO5Y76E / Aspirin
  •  go-up   go-down


Advertisement
4. Komeya M, Nakaigawa N, Sano F, Kagota M, Murakami T, Makiyama K, Miyoshi Y, Ogawa T, Uemura H, Yao M, Nagashima Y, Kubota Y: [A case of upper urinary tract metastases from sigmoid colon cancer]. Hinyokika Kiyo; 2009 Jun;55(6):339-43

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of upper urinary tract metastases from sigmoid colon cancer].
  • We report a case of colorectal cancer with metastasis to the upper urinary tract.
  • We diagnosed him with ureteral cancer and performed left nephroureterectomy.
  • Microscopic examination demonstrated adenocarcinoma located in ureteral and pelvic wall, especially in blood vessels, with intact mucosa and similar to adenocarcinoma of colon cancer.
  • Barium enema and positron emission tomography-CT demonstrated sigmoid colon cancer.
  • Biopsy specimen of colon cancer demonstrated adenocarcinoma, which was consistent with the ureteral tumor.
  • Finally we diagnosed him with metastatic upper urinary tract tumor of sigmoid colon cancer.
  • [MeSH-major] Adenocarcinoma / pathology. Adenocarcinoma / secondary. Sigmoid Neoplasms / pathology. Sigmoid Neoplasms / radiography. Ureteral Neoplasms / secondary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19588867.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


5. Chen JL, Huang TW, Hsu PS, Chao-Yang, Tsai CS: Cardiac tamponade as the initial manifestation of metastatic adenocarcinoma from the colon: a case report. Heart Surg Forum; 2007;10(4):E329-30
MedlinePlus Health Information. consumer health - Pericardial Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cardiac tamponade as the initial manifestation of metastatic adenocarcinoma from the colon: a case report.
  • Metastasis from colorectal cancer to the heart or pericardium is seldom reported and only sporadic antemortem cases have been reported.
  • We report an unusual case of malignant pericardial effusion caused by metastatic adenocarcinoma of colon.
  • [MeSH-major] Adenocarcinoma / complications. Cardiac Tamponade / etiology. Colonic Neoplasms / pathology. Heart Neoplasms / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17650460.001).
  • [ISSN] 1522-6662
  • [Journal-full-title] The heart surgery forum
  • [ISO-abbreviation] Heart Surg Forum
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


6. Wu CY: Muir-Torre syndrome: extraocular sebaceous carcinoma with adenocarcinoma of colon in a 76-year-old man. Clin Exp Dermatol; 2009 Oct;34(7):e399-400
Genetic Alliance. consumer health - Keratoacanthoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Muir-Torre syndrome: extraocular sebaceous carcinoma with adenocarcinoma of colon in a 76-year-old man.
  • [MeSH-major] Adenocarcinoma / diagnosis. Colonic Neoplasms / diagnosis. Facial Neoplasms / diagnosis. Muir-Torre Syndrome / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19549240.001).
  • [ISSN] 1365-2230
  • [Journal-full-title] Clinical and experimental dermatology
  • [ISO-abbreviation] Clin. Exp. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] England
  •  go-up   go-down


7. Sehgal R, McHayleh W, Reider JA, Cheema A, Ramanathan RK: Adenocarcinoma of colon presenting as Cushing's syndrome. J Clin Oncol; 2010 Mar 10;28(8):e126-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenocarcinoma of colon presenting as Cushing's syndrome.
  • [MeSH-major] Adenocarcinoma / complications. Colonic Neoplasms / complications. Cushing Syndrome / etiology

  • Genetic Alliance. consumer health - Cushing's Syndrome.
  • MedlinePlus Health Information. consumer health - Cushing's Syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20026802.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


8. Kim IA, Kim IH, Kim HJ, Chie EK, Kim JS: HDAC inhibitor-mediated radiosensitization in human carcinoma cells: a general phenomenon? J Radiat Res; 2010;51(3):257-63
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Regarding a potential application of HDI as a radiosensitizer in the treatment of solid tumors, an important question is whether treatment efficacy would be influenced by intrinsic differences between cancer cells, such as different histologic origin and status of ATM or p53.
  • First we have observed the in vitro radiosensitization by Trichostatin A (TSA) on the broad spectrum of human tumor cell lines having different histologic origin such as HCT116 adenocarcinoma of colon, A549 adenocarcinoma of lung, HN-3 squamous cell carcinoma of head/neck, and HeLa squamous carcinoma of uterine cervix, using clonogenic assay.
  • The data presented here indicate that HDI enhances the radiation induced cell killing in the various cancer cells having intrinsic differences and may serve as a general strategy for enhancing tumor cell radiosensitivity.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20505264.001).
  • [ISSN] 1349-9157
  • [Journal-full-title] Journal of radiation research
  • [ISO-abbreviation] J. Radiat. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Enzyme Inhibitors; 0 / Histone Deacetylase Inhibitors; 0 / Hydroxamic Acids; 0 / Radiation-Sensitizing Agents; 3X2S926L3Z / trichostatin A
  •  go-up   go-down


9. Chaleoykitti B: Preoperative diagnosis of urinary bladder involvement in adenocarcinoma of colon and rectum. J Med Assoc Thai; 2005 Dec;88(12):1816-20
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative diagnosis of urinary bladder involvement in adenocarcinoma of colon and rectum.
  • OBJECTIVE: Objective of the study was to compare urinary symptoms, urinalysis, computed tomography, intravenous pyelography, ultrasonography between colorectal adenocarcinoma with urinary bladder involvement and without urinary bladder involvement.
  • MATERIAL AND METHOD: Patients with adenocarcinoma of the colon and rectum who had the first operation between January 1999 and October 2004 were included in the present study.
  • CONCLUSION: History of urinary symptoms, urinalysis, computed tomography should be routinely performed in patients with adenocarcinoma of the sigmoid and rectum to detect urinary bladder involvement and to inform modes of urinary tract diversion to patients before surgery.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / pathology. Colonic Neoplasms / pathology. Rectal Neoplasms / pathology. Urinary Bladder Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16518979.001).
  • [ISSN] 0125-2208
  • [Journal-full-title] Journal of the Medical Association of Thailand = Chotmaihet thangphaet
  • [ISO-abbreviation] J Med Assoc Thai
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Thailand
  •  go-up   go-down


10. Chaleoykitti B: Comparative study between preoperative and postoperative histologic grading in adenocarcinoma of the colon and rectum. J Med Assoc Thai; 2005 Nov;88(11):1535-9
MedlinePlus Health Information. consumer health - After Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparative study between preoperative and postoperative histologic grading in adenocarcinoma of the colon and rectum.
  • BACKGROUND: Preoperative histologic grading was used to decide the length of the margin of resection in adenocarcinoma of colon and rectum.
  • MATERIAL AND METHOD: Preoperative and postoperative histologic grading of patients with adenocarcinoma of the colon and rectum in the department of surgery, Phramongkutklao Hospital between January 1999 and October 2004 were collected and compared together using percentage and chi-square test.
  • [MeSH-major] Adenocarcinoma / pathology. Colonic Neoplasms / pathology. Neoplasm Staging / standards. Postoperative Care / standards. Preoperative Care / standards. Rectal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16471098.001).
  • [ISSN] 0125-2208
  • [Journal-full-title] Journal of the Medical Association of Thailand = Chotmaihet thangphaet
  • [ISO-abbreviation] J Med Assoc Thai
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Thailand
  •  go-up   go-down


11. Zhu Y, Chen L: Identification and characterization of SP cells in human lung adenocarcinoma SPC-A1 cells. J Clin Oncol; 2009 May 20;27(15_suppl):e22230

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Identification and characterization of SP cells in human lung adenocarcinoma SPC-A1 cells.
  • With an extensive understanding of their biology, a major role for stem cells in the malignant process has been proposed and the existence of cancer stem cells(CSCs) has been confirmed in hematopoietic malignancies, brain cancer, and solid organ malignancies including breast, prostate, colon, and pancreatic cancer.
  • Lung cancer is the leading cause of cancer mortality in most large cities of China.
  • It is possible that lung cancer contains cancer stem cells responsible for its malignancy.
  • The aim of this study is to identify, characterize and enrich the CSC population that drives and maintains lung adenocarcinoma growth and metastasis.
  • METHODS: Side population (SP) cell analysis and sorting were applied to established human lung adenocarcinoma cell line and an attempt to further enrich them by preliminary serum-free culture before fluorescence activated cell sorting(FACS) was done.
  • RESULTS: Lung cancer cells could grow in a serum-free Medium (SFM) as non-adherent spheres similar to neurospheres or mammospheres.
  • Flow cytometric analysis of cell phenotyping showed that SP cells expressed CD133 and CD44, the common cell surface markers of cancer stem cells, while non-SP cells only expressed CD44.
  • CONCLUSIONS: SP cells existed in human lung adenocarcinoma cell lines and they could be further enriched by preliminary serum-free culture before FACS sorting.
  • SP cells possessed the properties of cancer stem cells.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964107.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Hu C, Xing Y, Cormier JN, Chang GJ: The validity of cause of death coding within the Surveillance, Epidemiology, and End Results (SEER) Registry. J Clin Oncol; 2009 May 20;27(15_suppl):6544

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : 6544 Background: Disease-specific survival (DSS) analysis within large cancer registries is more informative than other methods of survival analysis but requires accurate information regarding the cause of death (COD).
  • The purpose of this study was to evaluate the validity of the COD code for patients diagnosed with colon cancer and the extent to which it varies with regard to age, sex, and race within SEER.
  • METHODS: Patients with colon adenocarcinoma were identified from SEER (ver.
  • Colon cancer cause of death was then assigned using SEER COD recode for colon and rectal death (21040-50).
  • The number of observed and expected deaths by year was calculated to estimate deaths attributable to colon cancer.
  • Relative survival declined during the first 7 years of observation but then leveled indicating a minimum number of deaths subsequently attributable to colon cancer.
  • The difference (31,931) is theoretically attributable to colon cancer.
  • Within the SEER cohort, 30,227 deaths were coded colorectal cancer deaths, an estimated validity of 94.6%.
  • CONCLUSIONS: Cause of death coding for colon cancer in SEER is highly valid, suggesting that the use of DSS for colon cancer is appropriate.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964060.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


13. Overman MJ, Hu C, Wolff RA, Chang GJ: Impact of lymph node evaluation on survival for small bowel adenocaricnoma: Analysis of the Surveillance, Epidemiology and End Results (SEER) database. J Clin Oncol; 2009 May 20;27(15_suppl):4596

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : 4596 Background: Small bowel adenocarcinoma is a rare malignancy and is often associated with poor outcome.
  • METHODS: Patients aged 18-90 with adenocarcinoma of the small intestine diagnosed between 1988 and 2005 were identified from SEER data (ver. 2008).
  • CONCLUSIONS: As noted in colon cancer, the total number of LN assessed has considerable influence upon survival in stage I, II and III small bowel adenocarcinoma.
  • Stratifying stage III small bowel adenocarcinoma into those with <3 and ≥3 positive lymph nodes significantly improves prognostication for these patients and future staging systems should incorporate the number of positive nodes into nodal staging.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963112.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


14. Kim J, Chae Y, Sohn S, Kang B, Lee S, Lim K, Choi G, Baek J: -93G&gt;A polymorphism of hMLH1 associated with prognosis for patients with colorectal cancer. J Clin Oncol; 2009 May 20;27(15_suppl):4039

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] -93G>A polymorphism of hMLH1 associated with prognosis for patients with colorectal cancer.
  • : 4039 Background: Polymorphisms in the DNA repair genes may contribute to variation in DNA repair capacity, thereby affecting the risk of carcinogenesis and prognosis of colorectal cancer.
  • Accordingly, the present study analyzed polymorphisms of DNA repair genes and their impact on the prognosis for patients with colorectal cancer.
  • METHODS: Three hundred and ninety- seven consecutive patients with curatively resected colorectal adenocarcinoma were enrolled in the present study.
  • RESULTS: The median age of the patients was 63 years (range, 21-85), and 218 (54.9%) patients had colon cancer and 179 (45.1%) patients rectal cancer.
  • CONCLUSIONS: The -93G>A polymorphism of hMLH1 was found to be an independent prognostic marker for patients with colorectal cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961540.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


15. Marginean EC, Torlakovic G, Neufeld H, Torlakovic E: Association of upregulated GATA-4 transcription factor colorectal adenocarcinoma with metastatic and primary tumors. J Clin Oncol; 2009 May 20;27(15_suppl):e15093

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association of upregulated GATA-4 transcription factor colorectal adenocarcinoma with metastatic and primary tumors.
  • However, GATA-4 is not expressed in normal adult colonic mucosa.
  • Its protein expression in colonic adenocarcinoma has not been systematically evaluated and small number of samples was previously reported as negative.
  • Nuclear factor-B (NF-B) activation was shown to promote the growth of the colon tumors in experimental models and was correlated with tumor angiogenesis and progression in human colorectal cancer.
  • METHODS: Forty cases of colorectal adenocarcinoma were evaluated.
  • The benign colonic mucosa and the matching metastatic tumors of the same patients were also included in the study.
  • RESULTS: GATA-4 was expressed in 32% of colorectal adenocarcinoma, but not in benign colonic mucosa (p=0.0001, Chi-Square).
  • GATA-4 was also significantly more expressed in metastatic (41%) than in primary (21%) colorectal adenocarcinoma (p<0.0001, Chi-Square).
  • NF-B activation was not present in any of the samples of benign colonic mucosa, but it was detected in 64% adenocarcinomas (p<0.0001, Chi-Square).
  • While there was no difference in NF-B activation between primary vs. metastatic adenocarcinoma, a strong positive association between GATA-4 expression and NF-B activation (p<0.0001, Linear-by- Linear) was found.
  • CONCLUSIONS: GATA-4, a developmental transcription factor is not expressed by normal colonic mucosa, but is present in 1/5 of primary tumors that gave rise to distant metastases and in almost 1/2 of their respective metastases.
  • GATA- 4 is also strongly positively associated with NF-B activation previously described to have a role in human cancer progression.
  • GATA-4 may have a role in colorectal adenocarcinoma development and progression and it should be further evaluated in prospective studies as a putative adverse prognostic factor in colorectal adenocarcinoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964606.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


16. Fleischmann AM, Waser B, Reubi JC: Gastrin-releasing peptide receptors in the tumor vascular bed of various human cancers: high incidence in urinary tract cancers. J Clin Oncol; 2009 May 20;27(15_suppl):e14575

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • GRP-receptor overexpression has been detected in cancer cells and, more recently, also in the vascular bed of selected tumors.
  • More information on vascular GRP-receptors in cancer is required to asses their potential for vascular targeting applications.
  • METHODS: Frequent human cancers from the breast (n=134), lung (n=57), prostate (n=50), kidney (n=32), colon (n=46), urinary tract (n=26) and biliary tract (n=23) were analyzed using in vitro GRP-receptor autoradiography on tissue sections with the <sup>125</sup>I-[Tyr<sup>4</sup>]-bombesin radioligand and/or the universal radioligand <sup>125</sup>I-[D-Tyr<sup>6</sup>, ß-Ala<sup>11</sup>, Phe<sup>13</sup>, Nle<sup>14</sup>]-bombesin(6-14).
  • RESULTS: Prevalence of vascular GRP-receptors is variable, ranging from 13% (prostate cancer) to 92% (urinary tract cancer).
  • Different tumor-types within a given site may have divergent prevalence of vascular GRP-receptors (e.g. lung: small cell cancer: 0%; adenocarcinoma: 59%; squamous carcinoma: 83%).
  • Also the vascular score varies widely, with highest score in urinary tract cancer (1.69), moderate scores in lung (0.91), colon (0.88), kidney (0.84) and biliary tract (0.69) cancers and low scores in breast (0.39) and prostate (0.14) cancers.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963648.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Liang L, Wang XY, Zhang XH, Zhao WC, Deng HZ: [Screening on alkaloid of Sophora alopecuraides against adenocarcinoma of colon cell line SW620 in vitro]. Zhong Yao Cai; 2008 Jun;31(6):866-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Screening on alkaloid of Sophora alopecuraides against adenocarcinoma of colon cell line SW620 in vitro].
  • OBJECTIVE: To test 5 kinds of alkaloid of Sophora alopecuraides L., the effects of TBSA, MT, OMT, SC, SRI against adenocarcinoma of colon cell line SW620.
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / ultrastructure. Cell Line, Tumor. Colorectal Neoplasms / pathology. Colorectal Neoplasms / ultrastructure. Dose-Response Relationship, Drug. Drug Screening Assays, Antitumor. Flow Cytometry. Humans. Quinolizines / pharmacology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18998571.001).
  • [ISSN] 1001-4454
  • [Journal-full-title] Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials
  • [ISO-abbreviation] Zhong Yao Cai
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Alkaloids; 0 / Antineoplastic Agents, Phytogenic; 0 / Quinolizines; 519-02-8 / matrine
  •  go-up   go-down


18. Tracy RA, Chuang ST, Kim J, Coppola D: Correlation of expression of pro-apoptotic proteins bax and bak with lymph node metastasis in colonic adenocarcinoma. J Clin Oncol; 2009 May 20;27(15_suppl):e15042

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Correlation of expression of pro-apoptotic proteins bax and bak with lymph node metastasis in colonic adenocarcinoma.
  • : e15042 Background: Colon cancer has been associated with disturbances in the regulation of apoptosis.
  • Here we investigate how these two pro-apoptotic markers correlate with lymph node (LN) metastasis in colonic adenocarcinoma (CA).
  • The findings suggest a role for these markers in predicting stage and patient survival in colonic adenocarcinoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964458.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


19. Bayraktar UD, Bayraktar S, Herna S, Ku N, Jones C, Merchan J, Sands LR, Marchetti F, Montero A, Rocha-Lima CM: Does delay of adjuvant chemotherapy affect the clinical outcome in patients with colon cancer? J Clin Oncol; 2009 May 20;27(15_suppl):4046

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Does delay of adjuvant chemotherapy affect the clinical outcome in patients with colon cancer?
  • : 4046 Background: Adjuvant chemotherapy (AC) in patients with stage III colon adenocarcinoma prevents recurrences and improves survival.
  • We hypothesized that AC commenced within 60 days of resection would increase survival in patients with stage II and III colon cancer.
  • METHODS: Patients with newly diagnosed stage II or III colon adenocarcinoma who received fluoropyrimidine based AC in two centers (a private cancer center and a large community hospital) between 2000 and 2007 were included into analysis.
  • CONCLUSIONS: Delay of AC more than 60 days after resection is associated with inferior survival in stage II/III colon cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961564.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


20. Lenehan PF, Fry DW, Heyman ER, Eliason JF, Worzel WP: Generation and validation of a primary-tumor-derived four-gene prognostic signature for recurrence (R) of stages I/II colorectal cancer (CRC) following potentially curative resection. J Clin Oncol; 2009 May 20;27(15_suppl):4035

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Generation and validation of a primary-tumor-derived four-gene prognostic signature for recurrence (R) of stages I/II colorectal cancer (CRC) following potentially curative resection.
  • METHODS: Archival formalin-fixed paraffin-embedded (FFPE) primary adenocarcinoma tissues obtained at initial resection with curative intent were retrieved for 145 stage I/II (pT1-4 pN0 M0) CRC pts from multiple international sites; none had neoadjuvant or adjuvant therapy.
  • RR by stage (I/II) = 7.00/7.28 and tumor site (colon/rectum) = 8.75/4.50.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961545.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


21. Woell E, Greil R, Eisterer W, Fridrik M, Grünberger B, Zabernigg A, Mayrbäurl B, Russ G, Thaler J: Oxaliplatin, irinotecan, and cetuximab in advanced gastric cancer. First efficacy results of a multicenter phase II trial (AGMT Gastric-2) of the Arbeitsgemeinschaft Medikamentoese Tumortherapie (AGMT). J Clin Oncol; 2009 May 20;27(15_suppl):4538

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oxaliplatin, irinotecan, and cetuximab in advanced gastric cancer. First efficacy results of a multicenter phase II trial (AGMT Gastric-2) of the Arbeitsgemeinschaft Medikamentoese Tumortherapie (AGMT).
  • : 4538 Background: Patients (pts.) suffering from advanced gastric cancer have still a poor prognosis and treatment options are limited.
  • 51 patients with histological proven unresectable and/or metastatic gastric adenocarcinoma were treated in a first line setting.
  • 16 pts. went off-study due to neutropenia (n=5), nausea/vomiting (n=1), diarrhea (n=1), progressive disease (n=3), toxic colon (n=2), and allergic reaction to cetuximab at first (n=2), second (n=1) or third infusion (n=1).
  • CONCLUSIONS: The combination of oxaliplatin and irinotecan with cetuximab is feasible, safe and active in advanced gastric cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962987.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Yuan Y, Ma H, Cohen DJ, Ryan T, Choi H, Love' E, Awad M, Khambata-Ford S, Mauro D, Hochster H: Activity and tolerance of biweekly CapeOx-cetuximab in 1st line therapy of metastatic colorectal cancer (mCRC): Relation to K-ras mutation status. J Clin Oncol; 2009 May 20;27(15_suppl):e15018

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Activity and tolerance of biweekly CapeOx-cetuximab in 1st line therapy of metastatic colorectal cancer (mCRC): Relation to K-ras mutation status.
  • METHODS: Pts with previously untreated, histologically confirmed, metastatic colon adenocarcinoma, ECOG PS 0-1, and adequate organ function were eligible.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964423.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


23. Chaleoykitti B: Mucinous carcinoma of the colon and rectum in Phramongkutklao Hospital. J Med Assoc Thai; 2006 Jan;89(1):25-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mucinous carcinoma of the colon and rectum in Phramongkutklao Hospital.
  • OBJECTIVE: The objective of the present study was to compare the clinicopathological significance between mucinous carcinoma and nonmucinous adenocarcinoma.
  • MATERIAL AND METHOD: Patients with carcinoma of the colon and rectum who had the first operation in the Department of Surgery, Phramongkutklao Hospital between 1999 and 2004 were included in the present study.
  • CONCLUSION: Colorectal mucinous carcinoma had no clinicopathological difference from nonmucinous adenocarcinoma of colon and rectum.
  • [MeSH-major] Adenocarcinoma / pathology. Adenocarcinoma, Mucinous / pathology. Colonic Neoplasms / pathology. Rectal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16583577.001).
  • [ISSN] 0125-2208
  • [Journal-full-title] Journal of the Medical Association of Thailand = Chotmaihet thangphaet
  • [ISO-abbreviation] J Med Assoc Thai
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Thailand
  •  go-up   go-down


24. Mukaide H, Adachi Y, Taketani S, Iwasaki M, Koike-Kiriyama N, Shigematsu A, Shi M, Yanai S, Yoshioka K, Kamiyama Y, Ikehara S: FKBP51 expressed by both normal epithelial cells and adenocarcinoma of colon suppresses proliferation of colorectal adenocarcinoma. Cancer Invest; 2008 May;26(4):385-90
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] FKBP51 expressed by both normal epithelial cells and adenocarcinoma of colon suppresses proliferation of colorectal adenocarcinoma.
  • It has been reported, as a result of Western blot analyses, that FKBP51 is expressed in various tissues, but that it is not expressed in the pancreas, lung, colon, stomach, or spleen.
  • In this paper, we show, using Western blot analyses, reverse transcriptase polymerase chain reaction, and immunohistochemical analyses of samples from colon cancer patients, that both normal epithelial cells and adenocarcinoma in the human colon express FKBP51, and that there are no significant differences in the expressions of FKBP51 between them.
  • We also show that FKBP51 suppresses the proliferation of colorectal adenocarcinoma, possibly due to the suppression of functions of the glucocorticoid receptors.
  • [MeSH-major] Adenocarcinoma / metabolism. Colon / metabolism. Colorectal Neoplasms / metabolism. Neoplasm Proteins / physiology. Tacrolimus Binding Proteins / physiology

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • Hazardous Substances Data Bank. METHYLPREDNISOLONE .
  • Hazardous Substances Data Bank. MIFEPRISTONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18443959.001).
  • [ISSN] 1532-4192
  • [Journal-full-title] Cancer investigation
  • [ISO-abbreviation] Cancer Invest.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Neoplasm Proteins; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / RNA, Small Interfering; 0 / Receptors, Glucocorticoid; 320T6RNW1F / Mifepristone; EC 5.2.1.- / Tacrolimus Binding Proteins; EC 5.2.1.8 / tacrolimus binding protein 5; X4W7ZR7023 / Methylprednisolone
  •  go-up   go-down


25. Dong J, Yang J, Chen MQ, Wang XC, Wu ZP, Chen Y, Wang ZQ, Li M: A comparative study of gene vaccines encoding different extracellular domains of the vascular endothelial growth factor receptor 2 in the mouse model of colon adenocarcinoma CT-26. Cancer Biol Ther; 2008 Apr;7(4):502-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A comparative study of gene vaccines encoding different extracellular domains of the vascular endothelial growth factor receptor 2 in the mouse model of colon adenocarcinoma CT-26.
  • METHODS: Mouse model of CT-26 adenocarcinoma of colon were treated with orally immunized gene vaccine encoding extracellular 1-4 and full length of VEGFR2 respectively.
  • [MeSH-major] Adenocarcinoma / drug therapy. Cancer Vaccines / therapeutic use. Colonic Neoplasms / drug therapy. Vaccines, DNA / therapeutic use. Vascular Endothelial Growth Factor Receptor-2 / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18285704.001).
  • [ISSN] 1555-8576
  • [Journal-full-title] Cancer biology & therapy
  • [ISO-abbreviation] Cancer Biol. Ther.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies; 0 / Cancer Vaccines; 0 / Vaccines, DNA; EC 2.7.10.1 / Vascular Endothelial Growth Factor Receptor-2
  •  go-up   go-down


26. Omura Y, Horiuchi N, Jones MK, Lu DP, Shimotsuura Y, Duvvi H, Pallos A, Ohki M, Suetsugu A: Temporary anti-cancer & anti-pain effects of mechanical stimulation of any one of 3 front teeth (1st incisor, 2nd incisor, & canine) of right & left side of upper & lower jaws and their possible mechanism, & relatively long term disappearance of pain & cancer parameters by one optimal dose of DHEA, Astragalus, Boswellia Serrata, often with press needle stimulation of True ST. 36. Acupunct Electrother Res; 2009;34(3-4):175-203
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Temporary anti-cancer & anti-pain effects of mechanical stimulation of any one of 3 front teeth (1st incisor, 2nd incisor, & canine) of right & left side of upper & lower jaws and their possible mechanism, & relatively long term disappearance of pain & cancer parameters by one optimal dose of DHEA, Astragalus, Boswellia Serrata, often with press needle stimulation of True ST. 36.
  • One minute downward pressure on the tip of any one of the front 3 teeth (1st incisor, 2nd incisor, and canine) at the right and left sides of the upper and lower jaw by a wooden toothpick induced temporary disappearance (20 min approximately 4 hours) of abnormally increased pain parameters (pain grading, Substance P, & TXB2), and cancer parameters (Telomere, Integrin alpha5beta1, Oncogene C-fos Ab2, etc. of Astrocytoma, Glioblastoma, squamous cell carcinoma of esophagus, adenocarcinoma of lung, breast cancer, adenocarcinoma of colon, prostate cancer).
  • Repeated daily press needle stimulation of True ST.
  • One optimal dose of DHEA increased NC telomere 525 ng DBORT units and eliminated the pain and abnormally increased cancer parameters; effect of one optimal dose lasted 0.5-11 months.
  • One optimal dose of Boswellia Serrata or Astragalus not only increased NC telomere 650 ng BDORT units, eliminating pain and cancer parameters, but also reduced the size of the Astrocytoma grade I by 10-20% and the Glioblastoma by 15-90% in less than 2-6 months in some patients, as long as high NC telomere is maintained.

  • MedlinePlus Health Information. consumer health - Acupuncture.
  • MedlinePlus Health Information. consumer health - Pain.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20344885.001).
  • [ISSN] 0360-1293
  • [Journal-full-title] Acupuncture & electro-therapeutics research
  • [ISO-abbreviation] Acupunct Electrother Res
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Drugs, Chinese Herbal
  •  go-up   go-down


27. Perazzo F, Denninghoff V, Pasccon G, Pallotta MG, Tatangelo M, Cuartero V, Kirchuck R, Chacón M, Gennari L, Vera K, Avagnina A: Preliminary report of the mutation status of KRAS and BRAF-V600E in an Argentinean population of primary colorectal tumors. J Clin Oncol; 2009 May 20;27(15_suppl):e22183

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Patients were prospectively selected from the databases of 8 Argentinean public and private hospitals with colorectal cancer between January and December 2008.
  • 41.4% (60) have family history of cancer and 9.6% (14) have personal history of a previous tumor.
  • The primary tumor site was 21.9% (32) right colon, 5.5% (8) transverse colon, 45.2% (66) left colon and 27.4%(40) rectal cancer.
  • Adenocarcinoma was the unique histotype and mucinous differentiation was observed in 14.7% (21).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963599.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


28. Morán Y, Valderrama E, Camargo ME, Rivero MB, Chiurillo MA: [Chemiluminescent measurement of telomere DNA content in archival biopsies of colon adenocarcinoma]. Invest Clin; 2007 Dec;48(4):485-93

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Chemiluminescent measurement of telomere DNA content in archival biopsies of colon adenocarcinoma].
  • [Transliterated title] Determinación por quimioluminiscencia del contenido de telómero en biopsias de archivo de cáncer de colon.
  • Telomeres shorten with age, which can be associated to genomic instability and to an increment of the risk of suffering from cancer.
  • In this work, a slot blot assay was adapted to quantify the relative content, instead of the length, of telomeric DNA from paraffin-embedded archival specimens of colon adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / chemistry. Colonic Neoplasms / chemistry. DNA, Neoplasm / analysis. Luminescent Measurements / methods. Nucleic Acid Hybridization / methods. Telomere / chemistry

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18271393.001).
  • [ISSN] 0535-5133
  • [Journal-full-title] Investigación clínica
  • [ISO-abbreviation] Invest Clin
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Venezuela
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / DNA, Neoplasm; 0 / Strep-avidin conjugated horseradish peroxidase; EC 1.11.1.- / Horseradish Peroxidase
  •  go-up   go-down


29. Janeiro Pais JM, Busto Castañón L, Barbagelata López A, Diaz-Reixa JP, Romero Selás E, Casas Agudo VP, Gonzalez Martín M: [Metastasis of colon adenocarcinoma to the epididymis and spermatic cord]. Arch Esp Urol; 2006 Sep;59(7):746-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Metastasis of colon adenocarcinoma to the epididymis and spermatic cord].
  • [Transliterated title] Metástasis de adenocarcinoma de colon en epidídimo y cordón espermático.
  • OBJECTIVE: To report the case of an epididymal and spermatic cord metastasis of a colon adenocarcinoma.
  • METHODS/RESULTS: We present the case of a 67 years old man, who presents several months after subtotal left colectomy for a left colon adenocarcinoma (pT3 NoMo), with a symptomatic right palpable testicular tumour.
  • Right orchiectomy was done, demonstrating colon adenocarcinoma metastasis.
  • CONCLUSIONS: Epididymal and spermatic cord metastases are very infrequent and they usually are found incidentally after prostate cancer orchyectomy.
  • [MeSH-major] Adenocarcinoma / secondary. Colonic Neoplasms / pathology. Epididymis. Genital Neoplasms, Male / secondary. Spermatic Cord

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17078403.001).
  • [ISSN] 0004-0614
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


30. Sikorszki L, Horváth OP, Papp A, Cseke L, Pavlovics G: [Colon cancer after colon interposition for oesophageal replacement]. Magy Seb; 2010 Aug;63(4):157-60
Hazardous Substances Data Bank. HYDROGEN CHLORIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Colon cancer after colon interposition for oesophageal replacement].
  • [Transliterated title] Colonnal történt nyelőcsőpótlás után kialakult vastagbél-adenocarcinoma.
  • The authors report the case of a colon adenocarcinoma developed on the neck at the anastomosis of the skin tube and colon 44 years following a corrosive oesophageal injury.
  • 44 years later an ulcerated adenocarcinoma developed in the transposed colon, which was resected and the ability to swallow was reinstated by the transplantation of an isolated jejunal segment using microvascular anastomosis.
  • [MeSH-major] Adenocarcinoma / surgery. Burns, Chemical / complications. Cecal Neoplasms / surgery. Colon / transplantation. Esophagectomy. Esophagus / pathology. Jejunum / transplantation

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20724239.001).
  • [ISSN] 0025-0295
  • [Journal-full-title] Magyar sebészet
  • [ISO-abbreviation] Magy Seb
  • [Language] hun
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Hungary
  • [Chemical-registry-number] 0 / Caustics; QTT17582CB / Hydrochloric Acid
  •  go-up   go-down


31. Hong YS, Lee HJ, You CH, Roh MS, Kwak JY, Lee MJ, Kim JY: DNMT3b 39179GT polymorphism and the risk of adenocarcinoma of the colon in Koreans. Biochem Genet; 2007 Apr;45(3-4):155-63
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] DNMT3b 39179GT polymorphism and the risk of adenocarcinoma of the colon in Koreans.
  • DNMT3b SNP has been associated with susceptibility to lung, head, neck, and breast cancer, but its association with the development of colon cancer has not been reported.
  • We investigated the relationship between the 39179GT polymorphism in the DNMT3b gene, which is involved in de novo methylation and is associated with the risk of adenocarcinoma of the colon in Koreans.
  • The DNMT3b 39179GT genotypes were determined by a PCR-RFLP method in 248 adenocarcinomas of colon cancer patients and in 248 healthy controls matched as to age and sex.
  • The DNMT3b 39179GT polymorphism may be a genetic determinant of adenocarcinoma of the colon, especially in younger Korean men.
  • [MeSH-major] Adenocarcinoma / genetics. Asian Continental Ancestry Group / genetics. Colonic Neoplasms / genetics. DNA (Cytosine-5-)-Methyltransferase / genetics. Polymorphism, Single Nucleotide / genetics

  • Hazardous Substances Data Bank. GUANINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17318376.001).
  • [ISSN] 0006-2928
  • [Journal-full-title] Biochemical genetics
  • [ISO-abbreviation] Biochem. Genet.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 5Z93L87A1R / Guanine; EC 2.1.1.37 / DNA (Cytosine-5-)-Methyltransferase; EC 2.1.1.37 / DNA methyltransferase 3B; QR26YLT7LT / Thymine
  •  go-up   go-down


32. Ho YY, Lee WK: Metastasis to the breast from an adenocarcinoma of the colon. J Clin Ultrasound; 2009 May;37(4):239-41
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasis to the breast from an adenocarcinoma of the colon.
  • We report a case of metastasis to the breast from a colonic adenocarcinoma in a 50-year-old man who was 6 years status after a right hemicolectomy for T3N1M1 adenocarcinoma of the ascending colon.
  • The diagnosis of adenocarcinoma metastasis to the breast was achieved with sonographically guided core biopsy.
  • [MeSH-major] Adenocarcinoma / secondary. Breast Neoplasms / secondary. Breast Neoplasms / ultrasonography. Colonic Neoplasms / pathology. Ultrasonography, Mammary / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18461602.001).
  • [ISSN] 1097-0096
  • [Journal-full-title] Journal of clinical ultrasound : JCU
  • [ISO-abbreviation] J Clin Ultrasound
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


33. Fraguela Mariña JA, Fernández Blanco C, Alonso Fernández L, Taboada Filgueira L, Robles Veiga O, Gómez Freijoso C: [Liver metastases from colonic adenocarcinoma simulating cholangiocarcinoma]. Gastroenterol Hepatol; 2007 Oct;30(8):454-6
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Liver metastases from colonic adenocarcinoma simulating cholangiocarcinoma].
  • [Transliterated title] Metástasis hepática de cáncer de recto simulando un colangiocarcinoma.
  • Macroscopic intrabiliary growth of liver metastases from colonic adenocarcinoma mimicking cholangiocarcinoma, a pattern of intrahepatic spread easily confused with primary neoplasia of the biliary tract, is extremely infrequent.
  • We report a case of metastasis from adenocarcinoma of the colon that presented as a Klatskin tumor.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / secondary. Bile Duct Neoplasms / diagnosis. Cholangiocarcinoma / diagnosis. Colonic Neoplasms / pathology. Klatskin Tumor / diagnosis. Liver Neoplasms / diagnosis. Liver Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17949611.001).
  • [ISSN] 0210-5705
  • [Journal-full-title] Gastroenterología y hepatología
  • [ISO-abbreviation] Gastroenterol Hepatol
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


34. Wen Y, Giardina SF, Hamming D, Greenman J, Zachariah E, Bacolod MD, Liu H, Shia J, Amenta PS, Barany F, Paty P, Gerald W, Notterman D: GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1. Clin Cancer Res; 2006 Oct 15;12(20 Pt 1):5951-9
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1.
  • We found that the mRNA and protein products of GROalpha are more highly expressed in neoplastic than normal colon epithelium, and we studied potential mechanisms by which GROalpha may contribute to tumor initiation or growth.
  • GROalpha expression was determined by Affymetrix GeneChip (241 microdissected colon samples), real-time PCR (n = 32), and immunohistochemistry.
  • Primary colon cancer samples were also employed to determine copy number changes and loss of heterozygosity related to the GROalpha and fibulin-1 genes.
  • Expression of GROalpha mRNA was higher in primary adenocarcinomas (n = 132), adenomas (n = 32), and metastases (n = 52) than in normal colon epithelium (P < 0.001).
  • Samples of primary and metastatic colon cancer showed underexpression of fibulin-1 when compared with normal samples.
  • CONCLUSION: Elevated expression of GROalpha is frequent in adenocarcinoma of the colon and is associated with down-regulation of the matrix protein fibulin-1 in experimental models and in clinical samples.
  • Targeting GRO proteins may provide new opportunities for treatment of colon cancer.
  • [MeSH-major] Adenocarcinoma / genetics. Calcium-Binding Proteins / genetics. Chemokines, CXC / genetics. Colonic Neoplasms / genetics. Gene Expression Regulation, Neoplastic. Intercellular Signaling Peptides and Proteins / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17062666.001).
  • [ISSN] 1078-0432
  • [Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research
  • [ISO-abbreviation] Clin. Cancer Res.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P01-CA65930; United States / NCI NIH HHS / CA / P30-CA072720
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CXCL1 protein, human; 0 / Calcium-Binding Proteins; 0 / Chemokine CXCL1; 0 / Chemokines, CXC; 0 / DNA, Neoplasm; 0 / Intercellular Signaling Peptides and Proteins; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / fibulin
  •  go-up   go-down


35. Kanzaki H, Hirasaki S, Suzuki S, Matsubara M, Fujita K, Koide N: Early stage of colonic adenocarcinoma associated with traditional serrated adenoma. Intern Med; 2007;46(23):1911-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Early stage of colonic adenocarcinoma associated with traditional serrated adenoma.
  • We describe a 68-year-old woman diagnosed as having a colonic adenocarcinoma associated with traditional serrated adenoma (SA) with submucosal invasion of the sigmoid colon.
  • Colonoscopy revealed a 0-IIa+IIc colon cancer with a SA component, about 12 mm in diameter, in the sigmoid colon.
  • She underwent laparoscopy-assisted resection of the sigmoid colon.
  • In the resected specimen, colon cancer with mucin pools was adjacent to the SA.
  • Cases of colonic adenocarcinoma associated with traditional SA with submucosal invasion are relatively rare.
  • This case suggests that SA may play a role in the development of colorectal cancer.
  • [MeSH-major] Adenocarcinoma / pathology. Adenoma / pathology. Sigmoid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18057763.001).
  • [ISSN] 1349-7235
  • [Journal-full-title] Internal medicine (Tokyo, Japan)
  • [ISO-abbreviation] Intern. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


36. Petrişor O, Giuşcă SE, Sajin M, Dobrescu G: [Ki-67 and p53 expressions versus differentiation degrees of colon adenocarcinoma]. Rev Med Chir Soc Med Nat Iasi; 2008 Jan-Mar;112(1):183-90
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Ki-67 and p53 expressions versus differentiation degrees of colon adenocarcinoma].
  • [Transliterated title] Expresia ki-67 şi p53 în corelaţie cu gradul de diferenţiere al adenocarcinomului colonic.
  • PURPOSE: The colon carcinoma prognostic is evaluated with respect to four categories of factors established by College of American Pathologists Consensus Statement 1999, among which a series of molecular markers is also included.
  • Our study aimed to develop semiquantitative analysis of the immunohistochemistry pattern for proliferation and apoptosis markers, as well as of their connections with the histopathology subtypes of colon adenocarcinoma.
  • MATERIAL AND METHODS: The group of study included 5 cases of well-differentiated adenocarcinoma, 5 cases of moderately differentiated adenocarcinoma and 5 cases of poor differentiated adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / chemistry. Biomarkers, Tumor / analysis. Colonic Neoplasms / chemistry. Ki-67 Antigen / analysis. Tumor Suppressor Protein p53 / analysis

  • Hazardous Substances Data Bank. BIOTIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18677924.001).
  • [ISSN] 0048-7848
  • [Journal-full-title] Revista medico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i Naturaliş̧ti din Iaş̧i
  • [ISO-abbreviation] Rev Med Chir Soc Med Nat Iasi
  • [Language] rum
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Romania
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen; 0 / Tumor Suppressor Protein p53; 6SO6U10H04 / Biotin; 9013-20-1 / Streptavidin
  •  go-up   go-down


37. Ryoichi S, Hiroyuki M, Nobuyuki N, Tomohiro U, Jang KC: Colonic adenocarcinoma in an Indiana pouch successfully treated by endoscopic mucosal resection. Int J Urol; 2007 Jul;14(7):661-2
MedlinePlus Health Information. consumer health - Colonoscopy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Colonic adenocarcinoma in an Indiana pouch successfully treated by endoscopic mucosal resection.
  • We report the case of a 76-year-old woman who developed a colonic adenocarcinoma and a stone in an Indiana pouch 15 years after the urinary diversion.
  • The colonic adenocarcinoma was treated endoscopically and we were able to preserve the Indiana pouch.
  • To our knowledge, this is the sixth case of colonic adenocarcinoma in an Indiana pouch.
  • [MeSH-major] Adenocarcinoma / surgery. Colonic Neoplasms / surgery. Colonoscopy. Postoperative Complications / surgery. Urinary Reservoirs, Continent

  • MedlinePlus Health Information. consumer health - After Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17645616.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Australia
  • [Number-of-references] 8
  •  go-up   go-down


38. Szajda SD, Snarska J, Jankowska A, Roszkowska-Jakimiec W, Puchalski Z, Zwierz K: Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients. Hepatogastroenterology; 2008 Mar-Apr;55(82-83):388-93

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
  • Carcino-embryonic antigen (CEA) is a useful marker in oncological diagnostics of colorectal cancer.
  • CEA undergoes expression in all kinds of adenocarcinoma and is found both intercellularly and extracellularly.
  • The objective of this study has been to evaluate CD activity in the blood serum, urine and tumor tissues as well as in the colon biopsies which were not changed macroscopically and CEA concentration in the serum of colon adenocarcinoma, considering the extent of spread of cancer (TNM), the grade of the differentiation of cancer cell (G) as well as the tumor size.
  • The possibility of application of CD along with CEA as markers of colon adenocarcinoma has also been examined.
  • METHODOLOGY: The examination included the serum and urine of 21 patients as well as 12 tissues biopsies with histopathologically confirmed colon adenocarcinoma.
  • The reference group for the blood and urine comprised of 17 healthy controls, and for the colon adenocarcinoma tissues- samples collected from 14 people from the sites most distant from the resected tumor on the boundaries which were free of cancer cells.
  • RESULTS: CD activity was increased in the blood serum (p < 0.0001) and tissues (p = 0.022) of colon adenocarcinoma patients in comparison to the reference group.
  • CD specific activity has tendency to increase in colon adenocarcinoma tissues (p = 0.441) as compared to the reference group.
  • By examining data in regard to TNM clinical-histopathological classification, G and the tumor size, it could be concluded that CD activity in serum and urine in colon adenocarcinoma patients depends on progress of cancer in which CD activity increases with TNM.
  • A statistically significant increase in CEA concentration was found in the serum of colon adenocarcinoma patients, which was almost threefold higher than the in reference group.
  • CONCLUSIONS: The results of this study suggest that examination of CD activity and CEA concentration in serum, as well as CD activity in the urine, might be used in oncological diagnostics of colon adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / chemistry. Adenocarcinoma / metabolism. Carcinoembryonic Antigen / analysis. Cathepsin D / analysis. Colonic Neoplasms / chemistry. Colonic Neoplasms / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18613372.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Carcinoembryonic Antigen; EC 3.4.23.5 / Cathepsin D
  •  go-up   go-down


39. Nazim-Zygadło E, Dobosz P, Kochanowicz J, Czajecki K: [Metastasis from a colonic adenocarcinoma to the sphenoid sinus]. Otolaryngol Pol; 2005;59(3):429-32

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Metastasis from a colonic adenocarcinoma to the sphenoid sinus].
  • The authors present a very rare disease--metastasis of colon adenocarcinoma to the sphenoid sinus based on their own case.
  • [MeSH-major] Adenocarcinoma / secondary. Colonic Neoplasms / pathology. Paranasal Sinus Neoplasms / radiography. Paranasal Sinus Neoplasms / secondary. Sphenoid Sinus

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16117403.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


40. Shaco-Levy R, Sion-Vardy N, Piura B: Primary peritoneal malignant mixed müllerian tumor associated with colonic adenocarcinoma. Eur J Gynaecol Oncol; 2005;26(5):509-10
Genetic Alliance. consumer health - Malignant mixed Mullerian tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary peritoneal malignant mixed müllerian tumor associated with colonic adenocarcinoma.
  • Two cases coexisted with a colonic adenocarcinoma.
  • CASE: We report on a primary peritoneal MMMT diagnosed shortly after resection of a colonic adenocarcinoma in an 85-year-old woman who presented with a large omental mass.
  • CONCLUSIONS: This is the third case in the literature of primary extragenital MMMT occurring in association with colonic adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / diagnosis. Colonic Neoplasms / diagnosis. Mixed Tumor, Mullerian / diagnosis. Neoplasms, Multiple Primary / diagnosis. Peritoneal Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16285567.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


41. Ibele AR, Koplin SA, Slaughenhoupt BL, Kryger JV, Friedl A, Lund DP: Colonic adenocarcinoma in a 13-year-old with cystic fibrosis. J Pediatr Surg; 2007 Oct;42(10):E1-3
Hazardous Substances Data Bank. LEUCOVORIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Colonic adenocarcinoma in a 13-year-old with cystic fibrosis.
  • Here we report a case of colonic adenocarcinoma presenting as pneumaturia in a 13-year-old patient with cystic fibrosis.
  • [MeSH-major] Adenocarcinoma / complications. Cecal Neoplasms / complications. Cystic Fibrosis / complications

  • Genetic Alliance. consumer health - BabyFirstTest - Cystic Fibrosis.
  • Genetic Alliance. consumer health - Cystic Fibrosis.
  • MedlinePlus Health Information. consumer health - Cystic Fibrosis.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17923181.001).
  • [ISSN] 1531-5037
  • [Journal-full-title] Journal of pediatric surgery
  • [ISO-abbreviation] J. Pediatr. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Organoplatinum Compounds; 04ZR38536J / oxaliplatin; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil
  •  go-up   go-down


42. Wang Y, Li ZF, He J, Li YL, Zhu GB, Zhang LH, Li YL: Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis. Int J Colorectal Dis; 2007 Oct;22(10):1179-84

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis.
  • In this study, we used specific polyclonal antibodies against PRLs to investigate their expression in colonic adenocarcinomas and its correlation with patient gender, age, tumor differentiation, localization, invasion, and metastasis.
  • We also examined their expression in normal and pathologic tissues from the human colon.
  • The tissues included 49 primary colonic adenocarcinomas, 14 cases with lymph node metastases, 15 colonic adenomas, and 12 normal colon samples.
  • PRL-1, PRL-2, and PRL-3 were expressed, respectively, in 16, 10, and 16% of primary colonic adenocarcinomas.
  • There were no significant correlations between the expression of PRLs and patient gender, age, tumor differentiation, depth of invasion, or localization of tumor within the different sections of the colon.
  • PRLs were not expressed in normal colon tissues or in colonic adenomas.
  • PRLs were mainly expressed in the cytoplasm and at the cytoplasmic membranes of the colonic adenocarcinoma cells as well as in the endothelial cells and the surrounding smooth muscle cells of larger vessels in the lymph node metastases.
  • CONCLUSION: Colonic adenocarcinoma cells have the ability to produce PRLs, which may relate to the lymph node metastasis of colonic adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / enzymology. Cell Cycle Proteins / metabolism. Colonic Neoplasms / enzymology. Gene Expression Regulation, Neoplastic. Lymphatic Metastasis / pathology. Membrane Proteins / metabolism. Neoplasm Proteins / metabolism. Protein Tyrosine Phosphatases / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Physiol. 1996 Jul;271(1 Pt 1):G121-9 [8760115.001]
  • [Cites] Hybrid Hybridomics. 2004 Feb;23(1):23-7 [15000845.001]
  • [Cites] CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30 [15661684.001]
  • [Cites] J Biol Chem. 2000 Jul 14;275(28):21444-52 [10747914.001]
  • [Cites] Lancet Oncol. 2001 Jan;2(1):18-26 [11905614.001]
  • [Cites] Clin Cancer Res. 2003 Nov 15;9(15):5607-15 [14654542.001]
  • [Cites] Mol Cell Biol. 1994 Jun;14(6):3752-62 [8196618.001]
  • [Cites] Hum Genet. 1995 Nov;96(5):532-8 [8529999.001]
  • [Cites] Genomics. 1996 Jul 1;35(1):172-81 [8661118.001]
  • [Cites] J Clin Invest. 1993 Apr;91(4):1319-26 [8473485.001]
  • [Cites] Biochim Biophys Acta. 1998 Nov 8;1442(2-3):405-8 [9805001.001]
  • [Cites] Cancer Lett. 1996 Dec 20;110(1-2):49-55 [9018080.001]
  • [Cites] Science. 2001 Nov 9;294(5545):1343-6 [11598267.001]
  • [Cites] J Immunoassay. 1992;13(2):273-87 [1430243.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2648-57 [10937578.001]
  • [Cites] Cancer Res. 2003 Jun 1;63(11):2716-22 [12782572.001]
  • [Cites] Mol Cell Biol. 1991 Jan;11(1):381-90 [1986233.001]
  • (PMID = 17440740.001).
  • [ISSN] 0179-1958
  • [Journal-full-title] International journal of colorectal disease
  • [ISO-abbreviation] Int J Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Cell Cycle Proteins; 0 / Membrane Proteins; 0 / Neoplasm Proteins; EC 3.1.3.48 / PTP4A1 protein, human; EC 3.1.3.48 / PTP4A2 protein, human; EC 3.1.3.48 / PTP4A3 protein, human; EC 3.1.3.48 / Protein Tyrosine Phosphatases
  •  go-up   go-down


43. Rosbottom KJ, Michie B, Boyce S: Metastasis of recurrent colonic adenocarcinoma to the mouth. BMJ Case Rep; 2009;2009

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasis of recurrent colonic adenocarcinoma to the mouth.
  • Colorectal adenocarcinoma is a common cancer; however, reports of metastases to the oral region are uncommon.
  • We report the case of a 73-year-old man with recurrent metastatic disease who presented 2 years following his initial surgery for a left-sided colonic adenocarcinoma with a painful oral tumour.
  • Biopsy confirmed adenocarcinoma with similar features to the original colonic tumour; the patient went on to have palliation of his symptoms with radiotherapy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Oral Surg. 1975 Jan;33(1):53-6 [1053651.001]
  • [Cites] Br J Oral Maxillofac Surg. 2003 Feb;41(1):3-6 [12576032.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1965 Sep;20:350-62 [14342927.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1995 Nov;31B(6):355-60 [8746264.001]
  • [Cites] Ann Surg. 1940 Jul;112(1):138-49 [17857618.001]
  • [Cites] Oral Oncol. 2008 Aug;44(8):743-52 [18061527.001]
  • [Cites] J Oral Pathol. 1987 Aug;16(7):362-7 [3117991.001]
  • [Cites] J Natl Cancer Inst. 2004 Oct 6;96(19):1420-5 [15467030.001]
  • (PMID = 21754956.001).
  • [ISSN] 1757-790X
  • [Journal-full-title] BMJ case reports
  • [ISO-abbreviation] BMJ Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3028428
  •  go-up   go-down


44. Demirci U, Büyükberber S, Yilmaz G, Oztürk B, Akyürek N, Yildiz R, Tonyali O, Coşkun U, Benekli M: Coexistence Hodgkin's lymphoma and colonic adenocarcinoma: a case report. Med Oncol; 2010 Mar;27(1):62-4
Hazardous Substances Data Bank. FLUOROURACIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Coexistence Hodgkin's lymphoma and colonic adenocarcinoma: a case report.
  • We present the case of a patient having colonic adenocarcinoma and also incidentally found Hodgkin's lymphoma which involved a single mesenteric lymph node dissected from the sigmoidal resection performed for colonic carcinoma.
  • Coexistence of colonic carcinoma and lymphoma in the same patient is an uncommon event.
  • [MeSH-major] Adenocarcinoma / complications. Colonic Neoplasms / complications. Hodgkin Disease / complications

  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19205930.001).
  • [ISSN] 1559-131X
  • [Journal-full-title] Medical oncology (Northwood, London, England)
  • [ISO-abbreviation] Med. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0W860991D6 / Deoxycytidine; U3P01618RT / Fluorouracil; XELOX
  •  go-up   go-down


45. Sahani DV, Kalva SP, Fischman AJ, Kadavigere R, Blake M, Hahn PF, Saini S: Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. AJR Am J Roentgenol; 2005 Jul;185(1):239-46
Hazardous Substances Data Bank. MANGANESE, ELEMENTAL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
  • OBJECTIVE: The objective of our study was to assess the relative performance of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET for the detection of liver metastases from adenocarcinoma of the colon and pancreas.
  • MATERIALS AND METHODS: Imaging data of 34 patients (23 men, 11 women; age range, 44-78 years) with adenocarcinoma of the colon (n = 27) or adenocarcinoma of the pancreas (n = 7) who had undergone mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET were retrospectively reviewed for the presence and number of liver metastases.
  • CONCLUSION: In patients with colon and pancreatic adenocarcinoma, high-spatial-resolution mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET were comparable in the detection of patients with liver metastases.
  • [MeSH-major] Adenocarcinoma / secondary. Colonic Neoplasms / pathology. Liver Neoplasms / secondary. Magnetic Resonance Imaging / methods. Pancreatic Neoplasms / pathology. Positron-Emission Tomography

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Disodium EDTA .
  • Hazardous Substances Data Bank. ETHYLENEDIAMINE TETRAACETIC ACID .
  • Hazardous Substances Data Bank. DISODIUM CALCIUM EDTA .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15972430.001).
  • [ISSN] 0361-803X
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18; 42Z2K6ZL8P / Manganese; 5V5IOJ8338 / Pyridoxal Phosphate; 9G34HU7RV0 / Edetic Acid; P28BIW0UTB / N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
  •  go-up   go-down


46. Poulose SM, Harris ED, Patil BS: Antiproliferative effects of citrus limonoids against human neuroblastoma and colonic adenocarcinoma cells. Nutr Cancer; 2006;56(1):103-12
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Antiproliferative effects of citrus limonoids against human neuroblastoma and colonic adenocarcinoma cells.
  • Both highly purified forms were isolated from seeds and molasses of citrus fruits and tested for toxic effects against two human cancer cell lines, SH-SY5Y neuroblastoma and Caco-2 colonic adenocarcinoma, and a noncancerous mammalian epithelial Chinese hamster ovary (CHO) cells.
  • Viability, as quantified by 3-[4,5-dimethylthiazol- 2-yl]-2,5-diphenyltetrazolium reduction and light microscopy, was shortened significantly (P < 0.001) in cancer cells exposed to aglycones, viz., limonin, nomilin, obacunone, and deacetylnomilin.
  • The results confirm that limonoids exert a strong multifaceted lethal action against cancer cells, but are relatively ineffective against CHO cells.
  • [MeSH-minor] Animals. Apoptosis / drug effects. CHO Cells. Caco-2 Cells. Caspase 3 / drug effects. Caspase 3 / metabolism. Caspase 7 / drug effects. Caspase 7 / metabolism. Cell Death / drug effects. Cell Line, Tumor. Cell Survival / drug effects. Colonic Neoplasms / pathology. Cricetinae. Cricetulus. Dose-Response Relationship, Drug. Female. Flow Cytometry. Humans. Ovarian Neoplasms / pathology

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Herbal Medicine.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17176224.001).
  • [ISSN] 0163-5581
  • [Journal-full-title] Nutrition and cancer
  • [ISO-abbreviation] Nutr Cancer
  • [Language] eng
  • [Grant] United States / NIEHS NIH HHS / ES / ES 09106
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Limonins; EC 3.4.22.- / Caspase 3; EC 3.4.22.- / Caspase 7
  •  go-up   go-down


47. Gui X, Guzman G, Dobner PR, Kadkol SS: Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma. Peptides; 2008 Sep;29(9):1609-15
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma.
  • NT is expressed in fetal but not differentiated colonic epithelium and is re-expressed in colonic adenocarcinoma.
  • The cognate receptor, NTSR1, is also not expressed or is present at a low level in adult colonic epithelial cells but is expressed in most colon cancer cell lines.
  • These observations suggest that altered NT-NTSR1 signaling may be associated with malignant transformation in the colon.
  • To further understand the possible role of NTSR1 expression in colonic tumorigenesis and progression, we examined NTSR1 mRNA by in situ hybridization in normal colonic mucosa, adenomas, and colonic adenocarcinomas.
  • NTSR1 mRNA expression was undetectable or weak in superficial differentiated epithelial cells of normal colonic epithelium, but adenomas and adenocarcinomas showed moderate to strong expression (p<0.05).
  • Adenocarcinomas showed a higher level of expression compared to adenomas (p<0.05).
  • Furthermore, adenocarcinomas that infiltrated into and beyond the muscularis propria showed a higher intensity of NTSR1 expression compared with tumors that were localized to the mucosa or submucosa.
  • These results suggest that increased NTSR1 expression may be an early event during colonic tumorigenesis and also contribute to tumor progression and aggressive behavior in colonic adenocarcinomas.
  • NTSR1 may thus be a potential target for preventive or therapeutic strategies in colon cancer.
  • [MeSH-major] Adenocarcinoma / pathology. Colonic Neoplasms / pathology. Receptors, Neurotensin / biosynthesis

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18541341.001).
  • [ISSN] 0196-9781
  • [Journal-full-title] Peptides
  • [ISO-abbreviation] Peptides
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Messenger; 0 / Receptors, Neurotensin; 0 / neurotensin type 1 receptor
  •  go-up   go-down


48. Schetter AJ, Nguyen GH, Bowman ED, Mathé EA, Yuen ST, Hawkes JE, Croce CM, Leung SY, Harris CC: Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res; 2009 Sep 15;15(18):5878-87
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma.
  • PURPOSE: Inflammatory genes and microRNAs have roles in colon carcinogenesis; therefore, they may provide useful biomarkers for colon cancer.
  • This study examines the potential clinical utility of an inflammatory gene expression signature as a prognostic biomarker for colon cancer in addition to previously examined miR-21 expression.
  • EXPERIMENTAL DESIGN: Quantitative reverse transcriptase-PCR. was used to measure the expression of 23 inflammatory genes in colon adenocarcinomas and adjacent noncancerous tissues from 196 patients.
  • These data were used to develop models for cancer-specific mortality on a training cohort (n = 57), and this model was tested in both a test (n = 56) and a validation (n = 83) cohort.
  • IRS was associated with cancer-specific mortality in the training, test (P = 0.01), and validation (P = 0.02) cohorts.
  • Both IRS and miR-21 expression were independently associated with cancer-specific mortality, including stage II patients alone.
  • CONCLUSION: IRS and miR-21 expression are independent predictors of colon cancer prognosis and may provide a clinically useful tool to identify high-risk patients.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Blood. 2003 Apr 1;101(7):2620-7 [12411307.001]
  • [Cites] Med Oncol. 2009;26 Suppl 1:13-7 [19148594.001]
  • [Cites] N Engl J Med. 2004 Apr 29;350(18):1828-37 [15115829.001]
  • [Cites] Lancet. 1987 Jun 6;1(8545):1303-6 [2884421.001]
  • [Cites] Lancet. 1990 Aug 11;336(8711):357-9 [1975343.001]
  • [Cites] N Engl J Med. 1990 Nov 1;323(18):1228-33 [2215606.001]
  • [Cites] Int J Cancer. 1999 Jun 21;84(3):326-30 [10371355.001]
  • [Cites] Cancer Res. 1999 Aug 1;59(15):3698-704 [10446984.001]
  • [Cites] Cell. 2005 Mar 11;120(5):635-47 [15766527.001]
  • [Cites] Nature. 2005 Jun 9;435(7043):828-33 [15944707.001]
  • [Cites] J Immunol. 2005 Nov 1;175(9):6177-89 [16237115.001]
  • [Cites] N Engl J Med. 2005 Oct 27;353(17):1793-801 [16251535.001]
  • [Cites] Immunity. 2000 Nov;13(5):715-25 [11114383.001]
  • [Cites] Cancer. 2001 Feb 15;91(4):854-62 [11241255.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2002 Jun;282(6):G1035-44 [12016129.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):143-8 [12518062.001]
  • [Cites] Nat Rev Immunol. 2003 Feb;3(2):133-46 [12563297.001]
  • [Cites] N Engl J Med. 2005 Dec 22;353(25):2654-66 [16371631.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61 [16461460.001]
  • [Cites] Cancer Cell. 2006 Mar;9(3):189-98 [16530703.001]
  • [Cites] Cancer Cell. 2006 Aug;10(2):99-111 [16904609.001]
  • [Cites] Science. 2006 Sep 29;313(5795):1960-4 [17008531.001]
  • [Cites] Cancer Biother Radiopharm. 2006 Oct;21(5):468-87 [17105420.001]
  • [Cites] Annu Rev Med. 2007;58:239-52 [17100552.001]
  • [Cites] Eur J Cancer. 2007 Mar;43(4):762-8 [17258448.001]
  • [Cites] J Clin Invest. 2007 May;117(5):1175-83 [17476347.001]
  • [Cites] Blood. 2007 Aug 15;110(4):1330-3 [17496199.001]
  • [Cites] BMC Genomics. 2007;8:240 [17640343.001]
  • [Cites] J Natl Cancer Inst. 2007 Aug 15;99(16):1257-69 [17686824.001]
  • [Cites] Int J Cancer. 2007 Dec 1;121(11):2373-80 [17893866.001]
  • [Cites] PLoS One. 2007;2(10):e1020 [17925868.001]
  • [Cites] Nucleic Acids Res. 2008 Jan;36(Database issue):D149-53 [18158296.001]
  • [Cites] Cancer Metastasis Rev. 2008 Mar;27(1):11-8 [18066650.001]
  • [Cites] JAMA. 2008 Jan 30;299(4):425-36 [18230780.001]
  • [Cites] Lancet. 2008 Mar 1;371(9614):771-83 [18275997.001]
  • [Cites] CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 [18287387.001]
  • [Cites] Expert Rev Anticancer Ther. 2008 Apr;8(4):595-604 [18402526.001]
  • [Cites] J Mol Biol. 2008 May 2;378(3):492-504 [18384814.001]
  • [Cites] Gastroenterology. 2008 May;134(5):1296-310 [18471507.001]
  • [Cites] Gut. 2008 Jun;57(6):772-9 [17965063.001]
  • [Cites] N Engl J Med. 2008 Jun 19;358(25):2664-5 [18565858.001]
  • [Cites] Carcinogenesis. 2008 Jun;29(6):1202-6 [18448485.001]
  • [Cites] Immunol Rev. 2008 Jun;223:114-31 [18613832.001]
  • [Cites] Ann Oncol. 2008 Oct;19(10):1734-41 [18550579.001]
  • [Cites] Clin Cancer Res. 2008 Nov 1;14(21):6735-41 [18980965.001]
  • [Cites] Genome Res. 2009 Jan;19(1):92-105 [18955434.001]
  • [Cites] J Immunol. 2003 Jul 15;171(2):600-7 [12847224.001]
  • (PMID = 19737943.001).
  • [ISSN] 1078-0432
  • [Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research
  • [ISO-abbreviation] Clin. Cancer Res.
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / / Z99 CA999999; United States / Howard Hughes Medical Institute / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cytokines; 0 / MIRN21 microRNA, human; 0 / MicroRNAs
  • [Other-IDs] NLM/ NIHMS125003; NLM/ PMC2745503
  •  go-up   go-down


49. Carson HJ, Krivit JS, Eilers SG: Metastasis of colonic adenocarcinoma to the external ear canal: an unusual case with a complex-pattern of disease progression. Ear Nose Throat J; 2005 Jan;84(1):36-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasis of colonic adenocarcinoma to the external ear canal: an unusual case with a complex-pattern of disease progression.
  • We report on a patient who developed far-ranging metastases of adenocarcinoma of the colon that followed a gradual cephalad progression, including the right external ear canal, and led to hearing loss.
  • The patient was a 63-year-old white male with stage III adenocarcinoma of the colon.
  • Physical examination of the head and neck showed a mass in the external ear canal, and biopsy confirmed adenocarcinoma.
  • The significance of such wide-ranging metastases is that metastasis of adenocarcinoma to the ear did not signal imminent death, and relief of the hearing loss it caused was possible.
  • [MeSH-major] Adenocarcinoma / secondary. Colonic Neoplasms / pathology. Ear Canal. Ear Neoplasms / secondary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15742771.001).
  • [ISSN] 0145-5613
  • [Journal-full-title] Ear, nose, & throat journal
  • [ISO-abbreviation] Ear Nose Throat J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


50. Wang Y, Zhou ZG, Xia QJ, Zhang WY, Li HG, Wang R: [Expression of minichromosome maintenance protein 2 in colonic adenocarcinoma, adenoma and normal colonic mucosa and its clinical significance]. Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep;11(5):465-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Expression of minichromosome maintenance protein 2 in colonic adenocarcinoma, adenoma and normal colonic mucosa and its clinical significance].
  • OBJECTIVE: To investigate the expression differences of minichromosome maintenance 2 (MCM2) mRNA and protein among colon adenocarcinoma, colon adenoma and normal mucosa, and among different clinicopathological types of adenomas.
  • METHODS: Fifty specimens, including 33 colonic adenomas, 12 colonic adenocarcinomas and 5 normal colonic mucosa were selected.
  • Expression differences of MCM2 mRNA among the colonic adenocarcinoma, adenoma and normal colonic mucosa were evaluated by REST-XL software.
  • RESULTS: The expression of MCM2 was observed in the basal third to half of the colonic crypts in normal mucosa, while throughout the epithelium in the colonic adenocarcinomas and adenomas.
  • However, the expression of MCM2 mRNA in the adenocarcinomas was significantly higher than that in the adenomas(P=0.001).
  • CONCLUSION: The difference of MCM2 expression between the adenoma and the adenocarcinoma indicates its potential value in the early diagnosis of colonic cancer.
  • [MeSH-major] Adenocarcinoma / metabolism. Adenoma / metabolism. Cell Cycle Proteins / metabolism. Colonic Neoplasms / metabolism. Nuclear Proteins / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18803052.001).
  • [ISSN] 1671-0274
  • [Journal-full-title] Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
  • [ISO-abbreviation] Zhonghua Wei Chang Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cell Cycle Proteins; 0 / Nuclear Proteins; 0 / RNA, Messenger; EC 3.6.4.12 / MCM2 protein, human; EC 3.6.4.12 / Minichromosome Maintenance Complex Component 2
  •  go-up   go-down


51. Karasavvidou F, Potamianos SP, Barbanis S, Stathakis E, Psychos A, Kapsoritakis AN, Koukoulis G: Malakoplakia of the colon associated with colonic adenocarcinoma diagnosed in colonic biopsies. World J Gastroenterol; 2007 Dec 7;13(45):6109-11
Genetic Alliance. consumer health - Malakoplakia.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malakoplakia of the colon associated with colonic adenocarcinoma diagnosed in colonic biopsies.
  • Colonoscopy revealed a large malignant - appearing polypoid mass of the ascending colon and multiple distinct polyps throughout the rest of the colon.
  • Biopsies of the ascending colon mass confirmed the diagnosis of adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / complications. Colonic Neoplasms / complications. Malacoplakia / complications

  • Genetic Alliance. consumer health - Colonic Malakoplakia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18023111.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC4250902
  •  go-up   go-down


52. Rakheja D, Kapur P, Hoang MP, Roy LC, Bennett MJ: Increased ratio of saturated to unsaturated C18 fatty acids in colonic adenocarcinoma: implications for cryotherapy and lipid raft function. Med Hypotheses; 2005;65(6):1120-3
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Increased ratio of saturated to unsaturated C18 fatty acids in colonic adenocarcinoma: implications for cryotherapy and lipid raft function.
  • Mammalian fatty acid synthase (FASE) overexpression has been shown in a number of human malignancies including colonic adenocarcinoma.
  • Since FASE synthesizes only saturated fatty acids, we hypothesized that cancer cells have a greater proportion of long-chain saturated fatty acids.
  • We studied and found an unequivocal increase in saturated C18 fatty acid (stearic acid) in colonic adenocarcinoma compared to adjacent normal colonic mucosa.
  • This change in fatty acid composition of the cancer cells should significantly alter their physical and biological properties.
  • The increase in relative proportion of saturated fatty acids should make the cancer cells more susceptible to cryodamage and measurement of fatty acid composition of cancer cells may help individualize the temperature for cryotherapy.
  • Also, the lipid alterations may affect the structure and functions of lipid rafts, which may enable the cancer cells to affect signaling mechanisms such as those involved in cell growth and apoptosis.
  • Dietary or therapeutic interventions targeting lipid rafts may thus be an option for cancer treatment.
  • [MeSH-major] Adenocarcinoma / metabolism. Biomarkers, Tumor / metabolism. Colonic Neoplasms / metabolism. Colonic Neoplasms / therapy. Cryotherapy / methods. Fatty Acids / metabolism. Fatty Acids, Unsaturated / metabolism. Membrane Microdomains / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16084671.001).
  • [ISSN] 0306-9877
  • [Journal-full-title] Medical hypotheses
  • [ISO-abbreviation] Med. Hypotheses
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Fatty Acids; 0 / Fatty Acids, Unsaturated
  •  go-up   go-down


53. Sofocleous CT, Brown KT, Savage S, Brogi E, Covey AM, Brody LA, Schubert J, Getrajdman GI: Upper urinary tract metastases from adenocarcinoma of the colon. Acta Radiol; 2005 Jul;46(4):437-40
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Upper urinary tract metastases from adenocarcinoma of the colon.
  • Cytologic evaluation of aspirated material demonstrated metastatic colonic adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / secondary. Colonic Neoplasms / pathology. Urinary Tract / pathology. Urologic Neoplasms / diagnosis. Urologic Neoplasms / secondary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16134324.001).
  • [ISSN] 0284-1851
  • [Journal-full-title] Acta radiologica (Stockholm, Sweden : 1987)
  • [ISO-abbreviation] Acta Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Sweden
  •  go-up   go-down


54. Shen WW, Wu J, Cai L, Liu BY, Gao Y, Chen GQ, Fu GH: Expression of anion exchanger 1 sequestrates p16 in the cytoplasm in gastric and colonic adenocarcinoma. Neoplasia; 2007 Oct;9(10):812-9
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of anion exchanger 1 sequestrates p16 in the cytoplasm in gastric and colonic adenocarcinoma.
  • In this article, we show an unexpected expression of anion exchanger 1 (AE1) in the cytoplasm in poorly and moderately differentiated gastric and colonic adenocarcinoma cells and in its interaction with p16, thereby sequestrating the protein in the cytoplasm.
  • By analyzing tissue samples obtained from patients with gastric and colonic cancers, we found that 83.33% of gastric cancers and 56.52% of colonic cancers coexpressed AE1 and p16 in the cytoplasm.
  • We conclude that AE1 plays a crucial role in the pathogenesis of gastric and colonic adenocarcinoma and that p16 dysfunction is a novel pathway of carcinogenesis.
  • [MeSH-major] Adenocarcinoma / metabolism. Anion Exchange Protein 1, Erythrocyte / biosynthesis. Colonic Neoplasms / metabolism. Cyclin-Dependent Kinase Inhibitor p16 / metabolism. Stomach Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cell Biol. 2000 Sep 18;150(6):1467-78 [10995450.001]
  • [Cites] Oncogene. 2006 Jul 6;25(29):4116-21 [16491118.001]
  • [Cites] JOP. 2001 Jul;2(4 Suppl):171-5 [11875255.001]
  • [Cites] J Nephrol. 2002 Mar-Apr;15 Suppl 5:S41-53 [12027221.001]
  • [Cites] Exp Hematol. 2003 May;31(5):355-62 [12763133.001]
  • [Cites] Cancer Cell. 2004 Feb;5(2):121-5 [14998488.001]
  • [Cites] Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):11-27 [15000146.001]
  • [Cites] Biotech Histochem. 2004 Feb;79(1):5-10 [15223748.001]
  • [Cites] Biochem J. 1988 Feb 15;250(1):1-8 [2965576.001]
  • [Cites] J Biol Chem. 1990 Jan 5;265(1):462-71 [2294114.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Jul;87(14):5278-82 [2371270.001]
  • [Cites] Cancer Res. 1991 Nov 1;51(21):5800-5 [1933850.001]
  • [Cites] Cancer Res. 1992 Jun 1;52(11):3099-102 [1591722.001]
  • [Cites] Nature. 1993 Dec 16;366(6456):704-7 [8259215.001]
  • [Cites] Am J Physiol. 1993 Dec;265(6 Pt 2):F813-21 [7506871.001]
  • [Cites] Science. 1994 Apr 15;264(5157):436-40 [8153634.001]
  • [Cites] J Biol Chem. 1994 Dec 23;269(51):32201-8 [7798219.001]
  • [Cites] Cancer Res. 1995 Jun 15;55(12):2503-6 [7780957.001]
  • [Cites] J Clin Oncol. 1998 Mar;16(3):1197-206 [9508208.001]
  • [Cites] Nature. 1998 Mar 26;392(6674):402-5 [9537325.001]
  • [Cites] Br J Cancer. 1998 Dec;78(12):1661-8 [9862580.001]
  • [Cites] EMBO J. 1999 Apr 15;18(8):2106-18 [10205165.001]
  • [Cites] Biochem Cell Biol. 1998;76(5):709-13 [10353702.001]
  • [Cites] Int J Oncol. 2005 May;26(5):1217-26 [15809712.001]
  • [Cites] FEBS Lett. 2005 Apr 11;579(10):2105-10 [15811326.001]
  • [Cites] Oncogene. 2005 Apr 18;24(17):2787-95 [15838515.001]
  • [Cites] Gastroenterology. 2005 May;128(6):1696-716 [15887160.001]
  • [Cites] Curr Opin Nephrol Hypertens. 2005 Sep;14(5):495-501 [16046910.001]
  • [Cites] Exp Physiol. 2006 Jan;91(1):153-61 [16239253.001]
  • [Cites] Cancer Res. 2006 Feb 15;66(4):2129-37 [16489013.001]
  • [Cites] Neoplasia. 2006 Jan;8(1):46-51 [16533425.001]
  • [Cites] Neoplasia. 2006 Jun;8(6):429-36 [16820088.001]
  • [Cites] Ann N Y Acad Sci. 2000;915:81-91 [11193604.001]
  • (PMID = 17971901.001).
  • [ISSN] 1476-5586
  • [Journal-full-title] Neoplasia (New York, N.Y.)
  • [ISO-abbreviation] Neoplasia
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Anion Exchange Protein 1, Erythrocyte; 0 / Cyclin-Dependent Kinase Inhibitor p16; 0 / RNA, Small Interfering
  • [Other-IDs] NLM/ PMC2040208
  • [Keywords] NOTNLM ; Anion exchanger 1 / colonic adenocarcinoma / gastric adenocarcinoma / p16 / siRNA
  •  go-up   go-down


55. Tan KY, Ho KS, Lai JH, Lim JF, Ooi BS, Tang CL, Eu KW: Cutaneous and subcutaneous metastases of adenocarcinoma of the colon and rectum. Ann Acad Med Singapore; 2006 Aug;35(8):585-7
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cutaneous and subcutaneous metastases of adenocarcinoma of the colon and rectum.
  • CLINICAL PICTURE: The first case was a 70-year-old man with T3N2M0 rectal mucinous adenocarcinoma, who developed an inflammatory subcutaneous metastasis at the left scapula 2 years after anterior resection.
  • The second case was a 51-year-old man with T4N2M0 splenic flexure mucinous adenocarcinoma, who developed metastatic disease including a subcutaneous secondary to the back.
  • The third case was a 53-year-old woman who developed vulval recurrence 10 months after abdomino-perineal resection for a low T3N1M0 rectal adenocarcinoma.
  • A high index of suspicion is recommended when encountered with unresolving skin lesions in cancer patients.
  • [MeSH-major] Adenocarcinoma / secondary. Neoplasms, Connective Tissue / secondary. Rectal Neoplasms / pathology. Skin Neoplasms / secondary. Subcutaneous Tissue
  • [MeSH-minor] Adenocarcinoma, Mucinous / pathology. Adenocarcinoma, Mucinous / secondary. Aged. Female. Humans. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17006588.001).
  • [ISSN] 0304-4602
  • [Journal-full-title] Annals of the Academy of Medicine, Singapore
  • [ISO-abbreviation] Ann. Acad. Med. Singap.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Singapore
  •  go-up   go-down


56. Szumiło J, Swatek J, Chrościcki A, Dudka J, Korobowicz E: Colonic adenocarcinoma with numerous paneth and endocrine cells. Pol J Pathol; 2005;56(2):89-92
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Colonic adenocarcinoma with numerous paneth and endocrine cells.
  • Numerous granular eosinophilic cells corresponding to Paneth cells were unexpectedly revealed in a moderately differentiated adenocarcinoma of the hepatic flexure of the colon in a 76-year-old man.
  • [MeSH-major] Adenocarcinoma / pathology. Colorectal Neoplasms / pathology. Paneth Cells / pathology

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16092671.001).
  • [ISSN] 1233-9687
  • [Journal-full-title] Polish journal of pathology : official journal of the Polish Society of Pathologists
  • [ISO-abbreviation] Pol J Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Chromogranin A; 0 / Chromogranins
  •  go-up   go-down


57. Mutch MG: Molecular profiling and risk stratification of adenocarcinoma of the colon. J Surg Oncol; 2007 Dec 15;96(8):693-703
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular profiling and risk stratification of adenocarcinoma of the colon.
  • This manuscript examines several molecular markers that hope to improve staging for colon cancer.
  • [MeSH-major] Adenocarcinoma / genetics. Colonic Neoplasms / genetics. Gene Expression Profiling / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2007 Wiley-Liss, Inc
  • (PMID = 18081153.001).
  • [ISSN] 0022-4790
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Genetic Markers
  • [Number-of-references] 90
  •  go-up   go-down


58. Orts JA, Morell L, Camps J, Traba ML, Belenguer A, Guerrero A: [Multiple enterolithiasis, coexisting with bladder and gallbladder lithiasis, associated with colon adenocarcinoma]. An Med Interna; 2005 May;22(5):227-30
Hazardous Substances Data Bank. PHOSPHORUS, ELEMENTAL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Multiple enterolithiasis, coexisting with bladder and gallbladder lithiasis, associated with colon adenocarcinoma].
  • [Transliterated title] Enterolitiasis múltiple, coexistiendo con litiasis biliar y vesical, asociada a adenocarcinoma de colon.
  • We report a case of multiple enterolithiasis, very infrequent pathology, coexisting with bladder and gall bladder lithiasis in a patient with colon adenocarcinoma.
  • No risk factors for lithogenesis were found in this patient excluding the intestinal stasis caused by intestinal narrowing as a result of adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / complications. Calculi / complications. Cholelithiasis / complications. Colonic Neoplasms / complications. Intestinal Diseases / complications. Urinary Bladder Calculi / complications

  • MedlinePlus Health Information. consumer health - Gallstones.
  • Hazardous Substances Data Bank. MAGNESIUM, ELEMENTAL .
  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16001938.001).
  • [ISSN] 0212-7199
  • [Journal-full-title] Anales de medicina interna (Madrid, Spain : 1984)
  • [ISO-abbreviation] An Med Interna
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  • [Chemical-registry-number] 27YLU75U4W / Phosphorus; I38ZP9992A / Magnesium; SY7Q814VUP / Calcium
  •  go-up   go-down


59. Kusunoki N, Ito T, Sakurai N, Handa H, Kawai S: A celecoxib derivative potently inhibits proliferation of colon adenocarcinoma cells by induction of apoptosis. Anticancer Res; 2006 Sep-Oct;26(5A):3229-36

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A celecoxib derivative potently inhibits proliferation of colon adenocarcinoma cells by induction of apoptosis.
  • BACKGROUND: Celecoxib, a selective cyclooxygenase (COX)-2 inhibitor, has a pro-apoptotic effect on colon adenocarcinoma cells via COX-independent mechanisms.
  • MATERIALS AND METHODS: The pro-apoptotic effect of N-(2-Aminoethyl)-4-[5- (4-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide (TT101), a new derivative of celecoxib, was investigated on the HT-29 and SW480 colon adenocarcinoma cells.
  • CONCLUSION: A slight modification of celecoxib enhanced the pro-apoptotic effect on colon adenocarcinoma cells.
  • [MeSH-major] Adenocarcinoma / drug therapy. Apoptosis / drug effects. Cell Proliferation / drug effects. Colonic Neoplasms / drug therapy. Pyrazoles / pharmacology. Sulfonamides / pharmacology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17094434.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / 4-(5-(4-aminophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide; 0 / N-(2-aminoethyl)-4-(5-(4-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide; 0 / Pyrazoles; 0 / Sulfonamides; EC 3.4.22.- / Caspases; K7Q1JQR04M / Dinoprostone
  •  go-up   go-down


60. Espinoza-Cobos JC, Pérez-Figueroa J, Zúñiga-Ahuet G, Dorantes MA, Grube-Pagola P, Ruíz-Juárez I, Remes-Troche JM: [Oropharyngeal dysphagia as a first manifestation of dermatomyositis associated with colon cancer]. Rev Gastroenterol Mex; 2010 Oct-Dec;75(4):522-7
MedlinePlus Health Information. consumer health - Swallowing Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Oropharyngeal dysphagia as a first manifestation of dermatomyositis associated with colon cancer].
  • [Transliterated title] Disfagia orofaríngea como primera manifestación de dermatopolimiositis asociada a cáncer de colon.
  • There is a well-recognized association between DM and malignancies, including ovarian, breast, lung, and colon cancer.
  • We report a case of a male patient aged 85 with DM associated with colon adenocarcinoma; progressive dysphagia was the first manifestation, and subsequently proximal muscle weakness and typical skin lesions were present.
  • A colonoscopy study and histopathologic examination revealed the presence of adenocarcinoma of the colon.
  • [MeSH-major] Adenocarcinoma / complications. Colonic Neoplasms / complications. Deglutition Disorders / etiology. Dermatomyositis / complications. Paraneoplastic Syndromes / etiology

  • Genetic Alliance. consumer health - Dermatomyositis.
  • Genetic Alliance. consumer health - Dysphagia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21169124.001).
  • [ISSN] 0375-0906
  • [Journal-full-title] Revista de gastroenterología de México
  • [ISO-abbreviation] Rev Gastroenterol Mex
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


61. Al-Amri A, Al-Quorain AA: Coexisting malignant lymphoma of the duodenum and adenocarcinoma of the colon. Saudi Med J; 2007 Mar;28(3):463-4
MedlinePlus Health Information. consumer health - Intestinal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Coexisting malignant lymphoma of the duodenum and adenocarcinoma of the colon.
  • Synchronous malignant mucosa associated lymphoid tissue MALT-lymphoma of the small bowel and adenocarcinoma of the colon in the same patient is a scarce rarity.
  • Thus, it might be of interest to report such a case of coexisting malignant MALT-lymphoma of the duodenum and adenocarcinoma of the large bowel.
  • [MeSH-major] Adenocarcinoma / pathology. Colonic Neoplasms / pathology. Duodenal Neoplasms / pathology. Lymphoma, B-Cell, Marginal Zone / pathology. Neoplasms, Multiple Primary / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17334482.001).
  • [ISSN] 0379-5284
  • [Journal-full-title] Saudi medical journal
  • [ISO-abbreviation] Saudi Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Saudi Arabia
  •  go-up   go-down


62. Zhang MX, Cai H, Wang JS, Huang C, Wu WA, Ma RQ: [Expression profiles of microRNA in colon adenocarcinoma]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Oct;26(10):959-61

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Expression profiles of microRNA in colon adenocarcinoma].
  • AIM: to investigate the difference of microRNA (miRNA) expression profiles in colon adenocarcinoma and adjacent non-tumorous tissue (NT), for further studies on molecular mechanism of miRNA on colon adenocarcinoma.
  • METHODS: the fresh samples of 3 colon adenocarcinoma and NT were obtained and total RNA was isolated with TRIzol reagent.
  • RESULTS: 80 miRNAs with more than 2-fold change could be differentially expressed between NT and colon adenocarcinoma.
  • CONCLUSION: there were differentially expressed miRNAs in colon adenocarcinoma and NT.
  • These different miRNAs might be correlated to the process of carcinogenesis and progression of colon adenocarcinoma.
  • The miRNAs expression profiles might be an important molecular biomarker in the diagnosis of colon adenocarcinoma and target gene for tumor therapy.
  • [MeSH-major] Adenocarcinoma / genetics. Colonic Neoplasms / genetics. Gene Expression Profiling. Gene Expression Regulation, Neoplastic. MicroRNAs / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20937228.001).
  • [ISSN] 1007-8738
  • [Journal-full-title] Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
  • [ISO-abbreviation] Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / MicroRNAs
  •  go-up   go-down


63. Ma Q, Geng Y, Xu W, Wu Y, He F, Shu W, Huang M, Du H, Li M: The role of translationally controlled tumor protein in tumor growth and metastasis of colon adenocarcinoma cells. J Proteome Res; 2010 Jan;9(1):40-9
antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The role of translationally controlled tumor protein in tumor growth and metastasis of colon adenocarcinoma cells.
  • These results imply that TCTP might play at least a partial role in colon adenocarcinoma progression.
  • [MeSH-major] Adenocarcinoma / pathology. Biomarkers, Tumor / physiology. Colonic Neoplasms / pathology

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19621893.001).
  • [ISSN] 1535-3907
  • [Journal-full-title] Journal of proteome research
  • [ISO-abbreviation] J. Proteome Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / RNA, Small Interfering; 0 / tumor protein, translationally-controlled 1
  •  go-up   go-down


64. Read TE, Fleshman JW, Caushaj PF: Sentinel lymph node mapping for adenocarcinoma of the colon does not improve staging accuracy. Dis Colon Rectum; 2005 Jan;48(1):80-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sentinel lymph node mapping for adenocarcinoma of the colon does not improve staging accuracy.
  • PURPOSE: This study was designed to: determine the efficacy of sentinel lymph node mapping in patients with intraperitoneal colon cancer; and create an algorithm to predict potential survival benefit by using best-case estimates in favor of sentinel node mapping and lymph node ultraprocessing techniques.
  • METHODS: Forty-one patients with intraperitoneal colon cancer undergoing colectomy with curative intent were studied prospectively.
  • After mobilization of the colon and mesentery, 1 to 2 ml of isosulfan blue dye was injected subserosally around the tumor.
  • CONCLUSIONS: Sentinel node mapping with isosulfan blue dye and routine processing of retrieved nodes does not improve staging accuracy in patients with intraperitoneal colon cancer.
  • [MeSH-major] Adenocarcinoma / pathology. Algorithms. Colonic Neoplasms / pathology. Neoplasm Staging / methods. Sentinel Lymph Node Biopsy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15690662.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


65. Komai Y, Kawakita M, Shimada O, Muguruma K, Sakaida N, Matsuda T: Colonic adenocarcinoma and stones in an Indiana pouch. Int J Urol; 2005 Apr;12(4):412-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Colonic adenocarcinoma and stones in an Indiana pouch.
  • We report on a 63-year-old woman with adenocarcinoma and stones in an Indiana pouch.
  • Adenocarcinoma of an Indiana pouch is extremely rare.
  • To our knowledge, only four cases with adenocarcinoma in an Indiana pouch have been reported.
  • [MeSH-major] Adenocarcinoma / etiology. Colonic Neoplasms / etiology. Colonic Pouches / adverse effects. Urinary Calculi / etiology. Urinary Reservoirs, Continent / adverse effects
  • [MeSH-minor] Anastomosis, Surgical. Biopsy. Carcinoma, Transitional Cell / pathology. Carcinoma, Transitional Cell / surgery. Colon / surgery. Colonoscopy. Fatal Outcome. Female. Follow-Up Studies. Humans. Middle Aged. Nephrectomy. Reoperation. Tomography, X-Ray Computed. Ureter / surgery. Urinary Bladder Neoplasms / pathology. Urinary Bladder Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15948733.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


66. Mátrai Z, Péley G, Rényi Vámos F, Farkas E, Kovács T, Köves I: [The similarities between the mechanism of wound healing and tumor development--literature review on the occasion of a patient with colonic adenocarcinoma metastasis in a dog-bite wound]. Orv Hetil; 2005 Jan 16;146(3):99-109
MedlinePlus Health Information. consumer health - Animal Bites.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The similarities between the mechanism of wound healing and tumor development--literature review on the occasion of a patient with colonic adenocarcinoma metastasis in a dog-bite wound].
  • Based on these observations, the clinical relevance of surgical procedures comes up, may playing a role in tumor recurrence after primary resection for cancer.
  • This makes the opportunity of the development of completely new targeted approaches (antiangiogenic therapy, dormancy therapy) for the treatment of cancer.
  • This review article is based on a case report of a 63-year-old female patient who had colonic adenocarcinoma metastasis of the hand after biting by a dog.
  • [MeSH-major] Adenocarcinoma / secondary. Bites and Stings / pathology. Cell Transformation, Neoplastic. Colonic Neoplasms / pathology. Neovascularization, Pathologic. Wound Healing

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15693441.001).
  • [ISSN] 0030-6002
  • [Journal-full-title] Orvosi hetilap
  • [ISO-abbreviation] Orv Hetil
  • [Language] hun
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Hungary
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Antineoplastic Agents; 0 / Cell Adhesion Molecules; 0 / Growth Substances; 0 / Immunologic Factors
  • [Number-of-references] 48
  •  go-up   go-down


67. Szajda SD, Snarska J, Puchalski Z, Zwierz K: Lysosomal exoglycosidases in serum and urine of patients with colon adenocarcinoma. Hepatogastroenterology; 2008 May-Jun;55(84):921-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lysosomal exoglycosidases in serum and urine of patients with colon adenocarcinoma.
  • 3.2.1.24) in blood serum and urine in diagnostics of colon adenocarcinoma.
  • METHODOLOGY: The activity of lysosomal exoglycosidases was determined by the method of Marciniak et al. adapted to serum and urine of patients with adenocarcinoma of the colon.
  • RESULTS: A significant increase in concentration of the activity of HEX, GAL and FUC was found in blood serum, as well as HEX and GAL in urine, of patients with colon adenocarcinoma, in comparison with healthy people.
  • With the method of Marciniak et al. for determination the activity of HEX, GAL and FUC in blood serum as well as HEX and GAL in urine, the cases of colon adenocarcinoma were significantly differentiated from healthy people.
  • CONCLUSIONS: The high diagnostic value, sensitivity and specificity of the method of Marciniak et al., suggests the possibility of its use for determination of the activity of HEX, FUC and GAL in blood serum as well as HEX and GAL in urine, in the diagnostics of colon adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / enzymology. Biomarkers, Tumor / metabolism. Colonic Neoplasms / diagnosis. Colonic Neoplasms / enzymology. Glycoside Hydrolases / metabolism. Lysosomes / enzymology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18705298.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; EC 3.2.1.- / Glycoside Hydrolases; EC 3.2.1.23 / beta-Galactosidase; EC 3.2.1.24 / alpha-Mannosidase; EC 3.2.1.51 / alpha-L-Fucosidase; EC 3.2.1.52 / beta-N-Acetylhexosaminidases
  •  go-up   go-down


68. Vila Auli B, Pérez García D, Fernández Rodríguez C, Bañuls Polo P, Marín Pardo J: [Hepatopulmonary syndrome in a patient with adenocarcinoma of the colon metastatic to the liver and no apparent chronic liver disease]. Arch Bronconeumol; 2006 Sep;42(9):484-6
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Hepatopulmonary syndrome in a patient with adenocarcinoma of the colon metastatic to the liver and no apparent chronic liver disease].
  • [Transliterated title] Síndrome hepatopulmonar en paciente con adenocarcinoma de colon con metástasis hepáticas y sin hepatopatía crónica conocida.
  • We describe the case of a patient with hepatopulmonary syndrome and adenocarcinoma of the colon with metastases to a previously healthy liver.
  • [MeSH-major] Adenocarcinoma / secondary. Colonic Neoplasms / pathology. Hepatopulmonary Syndrome / etiology. Liver Neoplasms / secondary
  • [MeSH-minor] Colon / pathology. Colon / radiography. Colonoscopy. Humans. Liver / pathology. Liver / radiography. Liver Function Tests. Male. Middle Aged. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Liver Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17040663.001).
  • [ISSN] 0300-2896
  • [Journal-full-title] Archivos de bronconeumología
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


69. Marioni G, De Filippis C, Ottaviano G, Lorusso M, Staffieri C, Bernini G, Blandamura S: Laryngeal metastasis from sigmoid colon adenocarcinoma followed by peristomal recurrence. Acta Otolaryngol; 2006 Jun;126(6):661-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laryngeal metastasis from sigmoid colon adenocarcinoma followed by peristomal recurrence.
  • Colonic adenocarcinoma metastases to the larynx are extremely rare: only 13 cases have been described since 1972.
  • We present the first case of sigmoid colon adenocarcinoma metastasis to the larynx in a patient who developed peristomal malignancy recurrence after total laryngectomy.
  • Patients with metastasis of colonic adenocarcinoma to the larynx usually present with disseminated disease: in view of the poor chances of long-term survival of these patients conservative palliative laryngeal treatments should be carried out to improve the quality of life.
  • [MeSH-major] Adenocarcinoma / secondary. Laryngeal Neoplasms / secondary. Laryngectomy. Neoplasm Recurrence, Local / diagnosis. Sigmoid Neoplasms / diagnosis. Tracheostomy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16720454.001).
  • [ISSN] 0001-6489
  • [Journal-full-title] Acta oto-laryngologica
  • [ISO-abbreviation] Acta Otolaryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Norway
  •  go-up   go-down


70. Mirarchi M, De Raffele E, Lega S, Calculli L, Vaccari S, Cola B: [Synchronous adenocarcinoma of the sigmoid colon and multifocal intraductal papillary mucinous neoplasm of the pancreas in an elderly patient]. Chir Ital; 2009 May-Jun;61(3):357-67
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Synchronous adenocarcinoma of the sigmoid colon and multifocal intraductal papillary mucinous neoplasm of the pancreas in an elderly patient].
  • [Transliterated title] Adenocarcinoma del colon e neoplasia papillare intraduttale mucinosa multifocale sincrona del pancreas in un paziente anziano: caso clinico e revisione della letteratura.
  • A 78-year-old man presented with rectal bleeding which led to the diagnosis of a stenosing adenocarcinoma of the sigmoid colon.
  • The patient is still alive without evidence of cancer recurrence 33 month after the pancreatico-duodenectomy.
  • [MeSH-major] Adenocarcinoma / pathology. Adenocarcinoma, Mucinous / pathology. Adenocarcinoma, Papillary / pathology. Carcinoma, Pancreatic Ductal / pathology. Neoplasms, Multiple Primary / pathology. Pancreatic Neoplasms / pathology. Sigmoid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19694240.001).
  • [ISSN] 0009-4773
  • [Journal-full-title] Chirurgia italiana
  • [ISO-abbreviation] Chir Ital
  • [Language] ita
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


71. Royal RE, Pingpank JF Jr: Diagnosis and management of peritoneal carcinomatosis arising from adenocarcinoma of the colon and rectum. Semin Oncol; 2008 Apr;35(2):183-91

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis and management of peritoneal carcinomatosis arising from adenocarcinoma of the colon and rectum.
  • Peritoneal carcinomatosis (the implantation of tumor cells throughout the peritoneal cavity) occurs in as many as 50% of patients with colorectal cancer and in up to 25% is the only site of recurrence.
  • This chapter will provide an overview of the biologic basis of pathogenesis and the treatment of peritoneal metastases from colorectal cancer.
  • [MeSH-major] Adenocarcinoma / secondary. Colonic Neoplasms / pathology. Peritoneal Neoplasms / secondary. Rectal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18396204.001).
  • [ISSN] 0093-7754
  • [Journal-full-title] Seminars in oncology
  • [ISO-abbreviation] Semin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 54
  •  go-up   go-down


72. Kim SS, Nam JH, Kim SM, Choi YD, Lee JH: Peritoneal melanosis associated with mucinous cystadenoma of the ovary and adenocarcinoma of the colon. Int J Gynecol Pathol; 2010 Mar;29(2):113-6
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peritoneal melanosis associated with mucinous cystadenoma of the ovary and adenocarcinoma of the colon.
  • In this paper, we describe a case of peritoneal melanosis associated with a mucinous cystadenoma on an ovary and adenocarcinoma in the colon of 68-year-old women.
  • Pigment was also present in the wall of the mucinous cystadenoma of the ovary and colonic serosa.
  • [MeSH-major] Adenocarcinoma / pathology. Cystadenoma, Mucinous / pathology. Melanosis / pathology. Ovarian Neoplasms / pathology. Peritoneum / pathology. Sigmoid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20173496.001).
  • [ISSN] 1538-7151
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


73. Pérez LO, Abba MC, Laguens RM, Golijow CD: Analysis of adenocarcinoma of the colon and rectum: detection of human papillomavirus (HPV) DNA by polymerase chain reaction. Colorectal Dis; 2005 Sep;7(5):492-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Analysis of adenocarcinoma of the colon and rectum: detection of human papillomavirus (HPV) DNA by polymerase chain reaction.
  • OBJECTIVE: The aim of the present work was to evaluate the presence of human papillomavirus genotypes in malignant and normal mucosa of the colon and rectum in order to determine if a relationship exists between HPV infection and colon neoplasms.
  • MATERIALS AND METHODS: Thirty normal colon tissues and 54 sporadic adenocarcinomas were screened for HPV positivity using nested-PCR.
  • RESULTS: Significant differences in high risk HPV infection were found between normal samples and adenocarcinomas (P < 0.001).
  • CONCLUSION: The present study demonstrates that HPV may infect the glandular mucosa of the colon and suggests a possible association between HPV and colorectal cancer.
  • [MeSH-major] Adenocarcinoma / virology. Colonic Neoplasms / virology. Papillomaviridae / isolation & purification. Papillomavirus Infections / diagnosis. Rectal Neoplasms / virology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16108887.001).
  • [ISSN] 1462-8910
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA, Viral
  •  go-up   go-down


74. Youn JC, Rhee Y, Park SY, Kim WH, Kim SJ, Chung HC, Hong SW, Lim SK: Severe hypothyroidism induced by thyroid metastasis of colon adenocarcinoma: a case report and review of the literature. Endocr J; 2006 Jun;53(3):339-43
Hazardous Substances Data Bank. LEVOTHYROXINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Severe hypothyroidism induced by thyroid metastasis of colon adenocarcinoma: a case report and review of the literature.
  • An 85-year-old man who had undergone a right hemicolectomy for colon cancer presented with severe hypothyroidism and hoarseness 21 months after the operation.
  • Core biopsy of the thyroid gland showed invasion of poorly differentiated adenocarcinoma cells.
  • From these findings and the clinical observations, thyroid metastasis with hypothyroidism developing acutely from metastatic colon adenocarcinoma was diagnosed.
  • [MeSH-major] Adenocarcinoma / secondary. Colonic Neoplasms / pathology. Hypothyroidism / etiology. Thyroid Neoplasms / complications. Thyroid Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Hypothyroidism.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16714841.001).
  • [ISSN] 0918-8959
  • [Journal-full-title] Endocrine journal
  • [ISO-abbreviation] Endocr. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 9002-71-5 / Thyrotropin; Q51BO43MG4 / Thyroxine
  •  go-up   go-down


75. bin Sabir Husin Athar PP, bte Ahmad Norhan N, bin Saim L, bin Md Rose I, bte Ramli R: Metastasis to the sinonasal tract from sigmoid colon adenocarcinoma. Ann Acad Med Singapore; 2008 Sep;37(9):788-3
MedlinePlus Health Information. consumer health - Colorectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasis to the sinonasal tract from sigmoid colon adenocarcinoma.
  • INTRODUCTION: Metastatic adenocarcinoma from the gastrointestinal tract to the sinonasal tract is rare.
  • The histological morphology of this lesion is indistinguishable from the colonic variant of primary sinus adenocarcinoma or intestinal-type adenocarcinoma (ITAC).
  • CLINICAL PICTURE: This is a report of a case of metastatic adenocarcinoma of colorectal origin to the paranasal sinuses in a 52-year-old female who was previously treated for adenocarcinoma of the sigmoid colon.
  • A histologic study of the surgical specimen from the sinonasal cavity demonstrated a tumour identical to the patient's prior primary tumour of the colon.
  • The sinonasal neoplastic tissue showed marked positivity for carcinoembryonic antigen and expressed cytokeratin 20, which differentiates metastatic colonic adenocarcinoma from ITAC.
  • CONCLUSION: Distinguishing metastatic adenocarcinoma from gastrointestinal tract from ITAC can be difficult.
  • [MeSH-major] Adenocarcinoma / secondary. Colorectal Neoplasms / pathology. Paranasal Sinus Neoplasms / secondary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18989497.001).
  • [ISSN] 0304-4602
  • [Journal-full-title] Annals of the Academy of Medicine, Singapore
  • [ISO-abbreviation] Ann. Acad. Med. Singap.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Singapore
  • [Chemical-registry-number] 0 / Carcinoembryonic Antigen; 0 / Keratin-20
  •  go-up   go-down


76. Korekane H, Tsuji S, Noura S, Ohue M, Sasaki Y, Imaoka S, Miyamoto Y: Novel fucogangliosides found in human colon adenocarcinoma tissues by means of glycomic analysis. Anal Biochem; 2007 May 1;364(1):37-50
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Novel fucogangliosides found in human colon adenocarcinoma tissues by means of glycomic analysis.
  • The structures of acidic glycosphingolipids in colon adenocarcinoma have been analyzed extensively using a number of conventional methods, such as thin-layer chromatography and methylation analysis, and a variety of acidic glycosphingolipids present in the tissues have been reported.
  • In this technique, the carbohydrate moieties of acidic glycosphingolipids from approximately 20mg of colon adenocarcinoma were released by endoglycoceramidase II and were labeled by pyridylamination.
  • [MeSH-major] Acidic Glycosphingolipids / isolation & purification. Adenocarcinoma / chemistry. Biomarkers, Tumor / isolation & purification. Colonic Neoplasms / chemistry. Gangliosides / isolation & purification. Oligosaccharides, Branched-Chain / chemistry

  • Hazardous Substances Data Bank. 2-AMINOPYRIDINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17350584.001).
  • [ISSN] 0003-2697
  • [Journal-full-title] Analytical biochemistry
  • [ISO-abbreviation] Anal. Biochem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Acidic Glycosphingolipids; 0 / Aminopyridines; 0 / Biomarkers, Tumor; 0 / Gangliosides; 0 / Gels; 0 / Oligosaccharides, Branched-Chain; 0 / fucogangliosides; 3713-31-3 / Fucose; EC 3.2.1.- / Glycoside Hydrolases; EC 3.2.1.123 / endoglycoceramidase; WSX981HEWU / alpha-aminopyridine
  •  go-up   go-down


77. Buzzi N, Boland R, Russo de Boland A: Signal transduction pathways associated with ATP-induced proliferation of colon adenocarcinoma cells. Biochim Biophys Acta; 2010 Sep;1800(9):946-55
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Signal transduction pathways associated with ATP-induced proliferation of colon adenocarcinoma cells.
  • CONCLUSION: Extracellular ATP induces proliferation of Caco-2 human colonic cancer cells by activating MAPK cascades and modulation of transcription factors.
  • [MeSH-major] Adenocarcinoma / metabolism. Adenosine Triphosphate / pharmacology. Cell Proliferation / drug effects. Colonic Neoplasms / metabolism. Dual Specificity Phosphatase 1 / metabolism. MAP Kinase Signaling System / drug effects

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier B.V. All rights reserved.
  • (PMID = 20562007.001).
  • [ISSN] 0006-3002
  • [Journal-full-title] Biochimica et biophysica acta
  • [ISO-abbreviation] Biochim. Biophys. Acta
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Neoplasm Proteins; 0 / Protein Kinase Inhibitors; 0 / Purinergic P2 Receptor Agonists; 0 / Receptors, Purinergic P2; 0 / Transcription Factors; 8L70Q75FXE / Adenosine Triphosphate; EC 2.7.11.24 / Extracellular Signal-Regulated MAP Kinases; EC 3.1.3.48 / DUSP1 protein, human; EC 3.1.3.48 / Dual Specificity Phosphatase 1
  •  go-up   go-down


78. Nishigami T, Kataoka TR, Torii I, Sato A, Tamura K, Hirano H, Hida N, Ikeuchi H, Tsujimura T: Concomitant adenocarcinoma and colonic non-Hodgkin's lymphoma in a patient with ulcerative colitis: a case report and molecular analysis. Pathol Res Pract; 2010 Dec 15;206(12):846-50
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Concomitant adenocarcinoma and colonic non-Hodgkin's lymphoma in a patient with ulcerative colitis: a case report and molecular analysis.
  • Ulcerative colitis (UC) complicated by colonic lymphoma is rare, although UC is often accompanied by adenocarcinoma of the colon.
  • A concurrent existence of adenocarcinoma and lymphoma in a patient with UC is extremely rare, and has not yet been analyzed at the molecular level.
  • We report a 64-year-old female patient with concomitant adenocarcinoma and diffuse large B-cell lymphoma (DLBCL) in the colon of UC.
  • The colon adenocarcinomas had a mutation in MSH6 gene, DNA methylation in CDKN2A gene, and increased microsatellite instability (MSI), although these genetic changes were not recognized in either DLBCL or non-neoplastic UC mucosa.
  • The DLBCL was diagnosed as primary colonic lymphoma, and confirmed Epstein-Barr virus (EBV) infection.
  • The adenocarcinomas and the non-neoplastic UC mucosa were EBV-negative.
  • Our case presented here clearly shows that the development of adenocarcinoma and lymphoma in the colon with UC was caused by individual mechanisms.
  • [MeSH-major] Adenocarcinoma / genetics. Colitis, Ulcerative / pathology. Colonic Neoplasms / genetics. DNA-Binding Proteins / genetics. Genes, p16. Herpesvirus 4, Human. Lymphoma, Large B-Cell, Diffuse / pathology. Lymphoma, Large B-Cell, Diffuse / virology

  • Genetic Alliance. consumer health - Ulcerative Colitis.
  • MedlinePlus Health Information. consumer health - Ulcerative Colitis.
  • Hazardous Substances Data Bank. PREDNISOLONE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier GmbH. All rights reserved.
  • (PMID = 20846793.001).
  • [ISSN] 1618-0631
  • [Journal-full-title] Pathology, research and practice
  • [ISO-abbreviation] Pathol. Res. Pract.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 0 / DNA-Binding Proteins; 0 / G-T mismatch-binding protein; 9PHQ9Y1OLM / Prednisolone
  •  go-up   go-down


79. Shon YH, Nam KS: Chemopreventive effect of protein extract of Asterina pectinifera in HT-29 human colon adenocarcinoma cells. Arch Pharm Res; 2006 Mar;29(3):209-12
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chemopreventive effect of protein extract of Asterina pectinifera in HT-29 human colon adenocarcinoma cells.
  • We investigated the effect of protein extract of Asterina pectinifera on the activity of 4 enzymes that may play a role in adenocarcinoma of the colon: quinone reductase (QR), glutathione S-transferase (GST), ornithine decarboxylase (ODC), and cyclooxygenase (COX)-2.
  • QR and GST activity increased in HT-29 human colon adenocarcinoma cells increased that had been exposed to 4 concentrations of the protein extract (80, 160, 200, and 240 microg/mL).
  • These results suggest that this protein extract of A pectinifera has chemopreventive activity in HT-29 human colon adenocarcinoma cells, and therefore, may have the potential to function as a chemopreventive agent in human colorectal cancer.
  • [MeSH-minor] Adenocarcinoma. Colonic Neoplasms. Cyclooxygenase 2 / metabolism. Dose-Response Relationship, Drug. Glutathione Transferase / metabolism. Humans. NAD(P)H Dehydrogenase (Quinone) / metabolism. Ornithine Decarboxylase / metabolism. Ornithine Decarboxylase Inhibitors. Tetradecanoylphorbol Acetate

  • Hazardous Substances Data Bank. 12-O-TETRADECANOYLPHORBOL-13-ACETATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16596993.001).
  • [ISSN] 0253-6269
  • [Journal-full-title] Archives of pharmacal research
  • [ISO-abbreviation] Arch. Pharm. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Cyclooxygenase 2 Inhibitors; 0 / Ornithine Decarboxylase Inhibitors; 0 / Proteins; EC 1.14.99.1 / Cyclooxygenase 2; EC 1.6.5.2 / NAD(P)H Dehydrogenase (Quinone); EC 2.5.1.18 / Glutathione Transferase; EC 4.1.1.17 / Ornithine Decarboxylase; NI40JAQ945 / Tetradecanoylphorbol Acetate
  •  go-up   go-down


80. Qiao S, Iwashita T, Ichihara M, Murakumo Y, Yamaguchi A, Isogai M, Sakata K, Takahashi M: Increased expression of glial cell line-derived neurotrophic factor and neurturin in a case of colon adenocarcinoma associated with diffuse ganglioneuromatosis. Clin Neuropathol; 2009 Mar-Apr;28(2):105-12

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Increased expression of glial cell line-derived neurotrophic factor and neurturin in a case of colon adenocarcinoma associated with diffuse ganglioneuromatosis.
  • Here we describe a unique case of diffuse GN of the intestinal wall associated with colon adenocarcinoma occurring in a 38-year-old female.
  • Interestingly, GDNF as well as a related neurotrophic factor, neurturin (NTN), were expressed at high levels in adenocarcinoma cells whereas expression of GFR alpha 1 and RET was undetectable in them.
  • These findings suggested that GDNF and NTN expression in adenocarcinoma cells may play an important role in the pathogenesis of GN.
  • [MeSH-major] Adenocarcinoma / metabolism. Colonic Neoplasms / metabolism. Colonic Neoplasms / pathology. Enteric Nervous System / pathology. Ganglioneuroma / pathology. Glial Cell Line-Derived Neurotrophic Factor / metabolism. Neurturin / metabolism
  • [MeSH-minor] Adult. Cell Proliferation. Colon / metabolism. Colon / pathology. Female. Glial Cell Line-Derived Neurotrophic Factor Receptors / metabolism. Glial Fibrillary Acidic Protein / metabolism. Humans. Immunohistochemistry. Neuroglia / physiology. Proto-Oncogene Proteins c-ret / metabolism. S100 Proteins / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19353842.001).
  • [ISSN] 0722-5091
  • [Journal-full-title] Clinical neuropathology
  • [ISO-abbreviation] Clin. Neuropathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Glial Cell Line-Derived Neurotrophic Factor; 0 / Glial Cell Line-Derived Neurotrophic Factor Receptors; 0 / Glial Fibrillary Acidic Protein; 0 / Neurturin; 0 / S100 Proteins; EC 2.7.10.1 / Proto-Oncogene Proteins c-ret; EC 2.7.10.1 / RET protein, human
  •  go-up   go-down


81. Mason AC, Azari KK, Farkas LM, Duvvuri U, Myers EN: Metastatic adenocarcinoma of the colon presenting as a mass in the mandible. Head Neck; 2005 Aug;27(8):729-32

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic adenocarcinoma of the colon presenting as a mass in the mandible.
  • BACKGROUND: Metastatic adenocarcinoma of the colon is a frequently encountered medical situation.
  • Metastasis to the mandible from adenocarcinoma of the colon is very unusual and rarely reported.
  • We report the case of a 73-year-old man with metastatic adenocarcinoma to the mandible.
  • CT scans of the abdomen and pelvis revealed a 5-cm mass in the sigmoid colon with metastases to the liver.
  • RESULTS: A biopsy of the mass in the mandible was performed, and metastatic adenocarcinoma of colonic origin was diagnosed.
  • Colonoscopy and biopsy of the colonic mass substantiated that the sigmoid colon was the primary site of the cancer.
  • CONCLUSIONS: Although rare, metastatic adenocarcinoma from the colon to the mandible and parotid area should be included in the differential diagnosis of masses in this area.
  • After analysis of our case and a review of the literature, we conclude that metastasis from adenocarcinoma of the colon is quite rare and represents incurable disseminated disease.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / secondary. Mandibular Neoplasms / diagnosis. Mandibular Neoplasms / secondary. Sigmoid Neoplasms / pathology
  • [MeSH-minor] Aged. Biopsy. Colon, Sigmoid / radiography. Cranial Fossa, Middle. Diagnosis, Differential. Endoscopy. Fatal Outcome. Humans. Liver Neoplasms / secondary. Male. Mandible / pathology. Mandible / radiography. Pterygoid Muscles. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 Wiley Periodicals, Inc.
  • (PMID = 15920751.001).
  • [ISSN] 1043-3074
  • [Journal-full-title] Head & neck
  • [ISO-abbreviation] Head Neck
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


82. Kapoor S, Das B, Pal S, Sahni P, Chattopadhyay TK: En bloc resection of right-sided colonic adenocarcinoma with adjacent organ invasion. Int J Colorectal Dis; 2006 Apr;21(3):265-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] En bloc resection of right-sided colonic adenocarcinoma with adjacent organ invasion.
  • BACKGROUND: Right-sided colon cancers that invade the adjacent organs are often missed on preoperative imaging.
  • PATIENTS AND METHODS: The records of all patients who underwent en bloc resection of adjacent organs for right colon cancers were analyzed.
  • RESULTS: Between 1992 and 2004, 11 patients had an en bloc right hemicolectomy for right-sided colon cancer.
  • CONCLUSION: Right-sided colon cancers that invade adjacent organs in the absence of distant spread may be a subset of tumors that behave in a locally aggressive manner without causing hematogenous spread.
  • [MeSH-major] Adenocarcinoma / pathology. Adenocarcinoma / surgery. Colectomy. Colonic Neoplasms / pathology. Colonic Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surg Clin North Am. 1993 Feb;73(1):117-29 [8426992.001]
  • [Cites] World J Surg. 1999 Sep;23(9):907-12 [10449819.001]
  • [Cites] Dis Colon Rectum. 1987 May;30(5):337-41 [3568922.001]
  • [Cites] Arch Surg. 1982 May;117(5):595-9 [7073479.001]
  • [Cites] Surg Gynecol Obstet. 1953 Aug;97(2):177-82 [13077156.001]
  • [Cites] AJR Am J Roentgenol. 1993 Jan;160(1):49-52 [8416644.001]
  • [Cites] Ann Surg. 1972 Jun;175(6):892-9 [4260512.001]
  • [Cites] Dis Colon Rectum. 1991 Sep;34(9):780-3 [1717211.001]
  • [Cites] Surg Gynecol Obstet. 1985 Oct;161(4):319-22 [4049200.001]
  • [Cites] Br J Surg. 1972 Dec;59(12):932-5 [4661413.001]
  • [Cites] Clin Oncol. 1975 Mar;1(1):21-6 [1204268.001]
  • [Cites] Am J Surg. 1992 Jun;163(6):553-9 [1595834.001]
  • [Cites] Lancet. 1986 Oct 18;2(8512):904-7 [2876336.001]
  • [Cites] Am J Surg. 1987 Jul;154(1):67-71 [2440334.001]
  • [Cites] Dis Colon Rectum. 2000 Apr;43(4):460-5 [10789739.001]
  • [Cites] Cancer. 1988 Oct 15;62(8):1637-40 [3167778.001]
  • [Cites] J Am Coll Surg. 1994 Nov;179(5):587-92 [7952464.001]
  • [Cites] Hepatogastroenterology. 2001 Jan-Feb;48(37):114-7 [11268944.001]
  • [Cites] J Surg Oncol. 2002 Mar;79(3):194-7; discussion 198 [11870671.001]
  • (PMID = 15940511.001).
  • [ISSN] 0179-1958
  • [Journal-full-title] International journal of colorectal disease
  • [ISO-abbreviation] Int J Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


83. Barisella M, Lampis A, Perrone F, Carbone A: Clear cell adenocarcinoma of the colon is a unique morphological variant of intestinal carcinoma: case report with molecular analysis. World J Gastroenterol; 2008 Nov 14;14(42):6575-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clear cell adenocarcinoma of the colon is a unique morphological variant of intestinal carcinoma: case report with molecular analysis.
  • Here we report a new case of clear cell adenocarcinoma (CCA) of the colon in a 54-year-old Caucasian man.
  • Despite of the previous reported cases, the lesion was located in the right colon and was not associated with the conventional adenoma.
  • [MeSH-major] Adenocarcinoma, Clear Cell / chemistry. Adenocarcinoma, Clear Cell / genetics. Biomarkers, Tumor. Colonic Neoplasms / chemistry. Colonic Neoplasms / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Chir Ital. 2000 Jan-Feb;52(1):83-6 [10832531.001]
  • [Cites] Hum Mol Genet. 2001 Apr;10(7):721-33 [11257105.001]
  • [Cites] Int J Colorectal Dis. 2004 May;19(3):264-7 [14557891.001]
  • [Cites] Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4015-21 [15217933.001]
  • [Cites] Oncogene. 2004 Sep 23;23(44):7436-40 [15273715.001]
  • [Cites] J Clin Pathol. 1995 Dec;48(12):1142-4 [8568005.001]
  • [Cites] World J Gastroenterol. 2008 Feb 21;14(7):1137-40 [18286700.001]
  • [Cites] Histopathology. 1999 Mar;34(3):250-6 [10217566.001]
  • [Cites] Cancer. 1964 Feb;17:259-63 [14123687.001]
  • [Cites] Oncogene. 2006 Dec 4;25(57):7531-7 [17143297.001]
  • [Cites] Acta Gastroenterol Belg. 2007 Apr-Jun;70(2):235-8 [17715642.001]
  • [Cites] Clin Cancer Res. 2007 Sep 1;13(17):5034-40 [17785554.001]
  • [Cites] Int J Colorectal Dis. 2007 Dec;22(12):1543-4 [17186251.001]
  • [Cites] J Surg Oncol. 1998 Mar;67(3):182-5 [9530889.001]
  • (PMID = 19030216.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Other-IDs] NLM/ PMC2773350
  •  go-up   go-down


84. Soga K, Konishi H, Tatsumi N, Konishi C, Nakano K, Wakabayashi N, Mitsufuji S, Kataoka K, Okanoue T, Mukaisho K, Hattori T: Clear cell adenocarcinoma of the colon: a case report and review of literature. World J Gastroenterol; 2008 Feb 21;14(7):1137-40

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clear cell adenocarcinoma of the colon: a case report and review of literature.
  • A primary clear cell adenocarcinoma of the colon is a rare oncologic entity.
  • We herein report a case of such a tumor of the sigmoid colon in a 71-year-old woman who was successfully treated by an endoscopic polypectomy in our hospital.
  • We also reviewed the published reports regarding cases of primary clear cell tumors in the colon.
  • [MeSH-major] Adenocarcinoma, Clear Cell / pathology. Adenocarcinoma, Clear Cell / surgery. Colonic Neoplasms / pathology. Colonic Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Zhonghua Zhong Liu Za Zhi. 1993 Jan;15(1):61-4 [8334942.001]
  • [Cites] Tumori. 1992 Jun 30;78(3):219-20 [1440947.001]
  • [Cites] Eur Urol. 1997;31(1):73-80 [9032539.001]
  • [Cites] Int J Urol. 1996 Nov;3(6):501-3 [9170582.001]
  • [Cites] Urology. 1997 Oct;50(4):636-42 [9338750.001]
  • [Cites] J Surg Oncol. 1998 Mar;67(3):182-5 [9530889.001]
  • [Cites] Urology. 1998 Jun;51(6):1057-61 [9609655.001]
  • [Cites] Eur Urol. 1999;35(3):242-8 [10072628.001]
  • [Cites] Cancer. 1999 Apr 1;85(7):1593-8 [10193951.001]
  • [Cites] Histopathology. 1999 Mar;34(3):250-6 [10217566.001]
  • [Cites] Surg Today. 1999;29(5):449-52 [10333418.001]
  • [Cites] Cancer. 1964 Feb;17:259-63 [14123687.001]
  • [Cites] Arch Esp Urol. 2000 Jan-Feb;53(1):79-81 [10730432.001]
  • [Cites] World J Surg. 2000 Sep;24(9):1047-51 [11036280.001]
  • [Cites] J Clin Pathol. 2001 Jan;54(1):76-7 [11271795.001]
  • [Cites] Ann Ital Chir. 2000 Nov-Dec;71(6):643-7; discussion 647-8 [11347315.001]
  • [Cites] Urology. 2002 Apr;59(4):615-20 [11927338.001]
  • [Cites] Int J Colorectal Dis. 2004 May;19(3):264-7 [14557891.001]
  • [Cites] Int J Gynecol Cancer. 2004 Mar-Apr;14(2):259-70 [15086725.001]
  • [Cites] Union Med Can. 1976 Sep;105(9):1351-3 [969045.001]
  • [Cites] Obstet Gynecol. 1987 Oct;70(4):573-7 [3627626.001]
  • [Cites] Arch Pathol Lab Med. 1988 Feb;112(2):197-9 [3276291.001]
  • [Cites] Am J Obstet Gynecol. 1990 Jan;162(1):161-3 [2301485.001]
  • [Cites] Gynecol Oncol. 1990 Dec;39(3):314-20 [2258077.001]
  • [Cites] J Clin Pathol. 1995 Dec;48(12):1142-4 [8568005.001]
  • (PMID = 18286700.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] China
  • [Number-of-references] 25
  • [Other-IDs] NLM/ PMC2689421
  •  go-up   go-down


85. Sugiura T, Noguchi Y, Sakurai K, Hattori C: Protein phosphatase 1H, overexpressed in colon adenocarcinoma, is associated with CSE1L. Cancer Biol Ther; 2008 Feb;7(2):285-92

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Protein phosphatase 1H, overexpressed in colon adenocarcinoma, is associated with CSE1L.
  • In search for a new anticancer drug target, we explored genes involved in colon adenocarcinoma development through dysregulation of a signal transduction pathway.
  • By using the gene expression profile database, we found protein phosphatase 1H (PPM1H), belonging to the protein phosphatase 2C (PP2C) family, upregulated in colon adenocarcinomas compared with normal colon tissues.
  • RT-PCR analysis verified the elevated level of PPM1H expression in colon cancer cell lines relative to a normal colon cell line.
  • PPM1H controls cell cycle and proliferation of cancer cells potentially through dephosphorylation of CSE1L and might be a new target of anticancer drugs.
  • [MeSH-major] Adenocarcinoma / metabolism. Cellular Apoptosis Susceptibility Protein / metabolism. Colonic Neoplasms / metabolism. Gene Expression Regulation, Neoplastic. Phosphoprotein Phosphatases / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Cancer Biol Ther. 2008 Feb;7(2):293-4 [18623903.001]
  • (PMID = 18059182.001).
  • [ISSN] 1555-8576
  • [Journal-full-title] Cancer biology & therapy
  • [ISO-abbreviation] Cancer Biol. Ther.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cellular Apoptosis Susceptibility Protein; EC 3.1.3.16 / PPM1H protein, human; EC 3.1.3.16 / Phosphoprotein Phosphatases; EC 3.1.3.16 / protein phosphatase 2C
  •  go-up   go-down


86. Laingo Andrianarison JF, Ranoharison D, Rakotoarivelo RA, Razafimahefa SH, Andriamampionona TF, Rabarijaona L, Rafaramino F, Rajaona HR: [A misleading case of hypereosinophilia revealing colonic adenocarcinoma in a patient from a tropical area]. Med Trop (Mars); 2009 Oct;69(5):517-9
MedlinePlus Health Information. consumer health - Eosinophilic Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A misleading case of hypereosinophilia revealing colonic adenocarcinoma in a patient from a tropical area].
  • Although paraneoplastic hypereosinophilia has been documented in patients with colon cancer, this association is rare.
  • The purpose of this report is to describe a case of paraneoplastic hypereosinophilia associated with colic adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / diagnosis. Eosinophilia / etiology. Sigmoid Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20025189.001).
  • [ISSN] 0025-682X
  • [Journal-full-title] Médecine tropicale : revue du Corps de santé colonial
  • [ISO-abbreviation] Med Trop (Mars)
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


87. Klenow S, Glei M, Haber B, Owen R, Pool-Zobel BL: Carob fibre compounds modulate parameters of cell growth differently in human HT29 colon adenocarcinoma cells than in LT97 colon adenoma cells. Food Chem Toxicol; 2008 Apr;46(4):1389-97
Hazardous Substances Data Bank. HYDROGEN PEROXIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Carob fibre compounds modulate parameters of cell growth differently in human HT29 colon adenocarcinoma cells than in LT97 colon adenoma cells.
  • An extract of the Mediterranean carob (Ceratonia siliqua L.) pod (carob fibre extract), products formed after its fermentation by the gut flora and the major phenolic ingredient gallic acid (GA), were comparatively investigated for their influence on survival and growth parameters of colon adenocarcinoma HT29 cells and adenoma LT97 cells.
  • The differently modulated growth of human colon cell lines was more related to proliferation rates and impairment of DNA-synthesis than to H2O2 formation.
  • [MeSH-major] Adenocarcinoma / pathology. Adenoma / pathology. Antineoplastic Agents, Phytogenic. Cell Division / drug effects. Colonic Neoplasms / pathology. Dietary Fiber / pharmacology. Fabaceae / chemistry

  • MedlinePlus Health Information. consumer health - Dietary Fiber.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17950517.001).
  • [ISSN] 0278-6915
  • [Journal-full-title] Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
  • [ISO-abbreviation] Food Chem. Toxicol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / Culture Media; 0 / DNA, Neoplasm; 0 / Phenols; 0 / Sulfoxides; 0 / Xylenes; BBX060AN9V / Hydrogen Peroxide; S2VDY878QD / xylenol orange
  •  go-up   go-down


88. Alvarez-Alvarez C, Iglesias-Rodríguez B, Pazo-Irazu S, Delgado-Sánchez-Gracián C: Colonic adenocarcinoma with metastasis to the gingiva. Med Oral Patol Oral Cir Bucal; 2006 Jan;11(1):E85-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Colonic adenocarcinoma with metastasis to the gingiva.
  • We report the case of a 62-year-old male who had been diagnosed with sigmoid adenocarcinoma with nodal and liver metastasis, who presented 6 months later with a gingival polypoid tumor, at first considered as a primary neoplasm of gingiva, that was diagnosed in a biopsy as metastatic intestinal adenocarcinoma.
  • The histological evaluation is essential to separate adenocarcinoma from the commoner in this site squamous cell carcinoma, and the immunohistochemical techniques are useful to distinguish metastatic tumor versus primary adenocarcinoma from the minor salivary glands of the area.
  • [MeSH-major] Adenocarcinoma / secondary. Gingival Neoplasms / secondary. Mandibular Neoplasms / secondary. Sigmoid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16388302.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng; spa
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


89. Tzilves D, Moschos J, Paikos D, Tagarakis G, Pilpilidis I, Soufleris K, Kadis S, Tarpagos A, Katsos I: Synchronous occurrence of a primary colon adenocarcinoma and a gastric stromal tumor. A case report. Minerva Gastroenterol Dietol; 2008 Mar;54(1):101-3
MedlinePlus Health Information. consumer health - Stomach Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous occurrence of a primary colon adenocarcinoma and a gastric stromal tumor. A case report.
  • The colonoscopy showed a large tumor of the sigmoid and the gastroscopy a large gastric tumor of the antrum, which were histologically diagnosed as colonic adenocarcinoma and gastric stromal tumor respectively.
  • To our best knowledge, this is the second report of a synchronous gastric stromal tumor and a colonic adenocarcinoma in medical literature.
  • [MeSH-major] Adenocarcinoma / pathology. Colonic Neoplasms / pathology. Gastrointestinal Stromal Tumors / pathology. Neoplasms, Multiple Primary / pathology. Stomach Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18299673.001).
  • [ISSN] 1121-421X
  • [Journal-full-title] Minerva gastroenterologica e dietologica
  • [ISO-abbreviation] Minerva Gastroenterol Dietol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


90. Brown AC, Reitzenstein JE, Liu J, Jadus MR: The anti-cancer effects of poi (Colocasia esculenta) on colonic adenocarcinoma cells In vitro. Phytother Res; 2005 Sep;19(9):767-71
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The anti-cancer effects of poi (Colocasia esculenta) on colonic adenocarcinoma cells In vitro.
  • Hawaiians tend to have lower incidence rates of colorectal cancer and it was hypothesized that this may be due to ethnic differences in diet, specifically, their consumption of poi, a starchy paste made from the taro (Colocasia esulenta L.) plant corm.
  • Soluble extracts of poi were incubated at 100 mg/mL in vitro for antiproliferative activity against the rat YYT colon cancer cell line. (3)H-thymidine incorporation studies were conducted to demonstrate that the poi inhibited the proliferation of these cancer cells in a dose-dependent manner.
  • The greatest suppression of YYT colon cancer growth occurred when 25% concentration was used.
  • Although numerous factors can contribute to the risk of colon cancer, perhaps poi consumption may contribute to the lower colon cancer rates among Hawaiians by two distinct mechanisms.
  • First, by inducing apoptosis within colon cancer cells; second, by non-specifically activating lymphocytes, which in turn can lyse cancerous cells.
  • Our results suggest for the first time that poi may have novel tumor specific anti-cancer activities and future research is suggested with animal studies and human clinical trials.
  • [MeSH-minor] Adenocarcinoma / prevention & control. Animals. Cell Line, Tumor / drug effects. Colonic Neoplasms / prevention & control. Flow Cytometry. Hawaii. In Vitro Techniques. Medicine, Traditional. Rats

  • MedlinePlus Health Information. consumer health - Herbal Medicine.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 John Wiley & Sons, Ltd.
  • (PMID = 16220568.001).
  • [ISSN] 0951-418X
  • [Journal-full-title] Phytotherapy research : PTR
  • [ISO-abbreviation] Phytother Res
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / Plant Extracts
  •  go-up   go-down


91. Brahmania M, Kanthan CS, Kanthan R: Collision tumor of the colon--colonic adenocarcinoma and ovarian granulosa cell tumor. World J Surg Oncol; 2007;5:118
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Collision tumor of the colon--colonic adenocarcinoma and ovarian granulosa cell tumor.
  • BACKGROUND: Collision tumors of the colon are rare.
  • We report the first case, to our knowledge in the English literature, of a collision tumor composed of a colonic adenocarcinoma arising in a sigmoid diverticulum coexisting with a recurrent ovarian granulosa cell tumor.
  • Surgical removal of the mass and pathological examination revealed the presence of a colonic adenocarcinoma arising in a large sigmoid diverticulum coexistent with a second neoplastic tumor phenotype; confirmed to be a delayed recurrent ovarian granulosa cell tumor.
  • CONCLUSION: Collision tumors of the colon are rare.
  • This is the first case reported of a collision tumor composed of adenocarcinoma colon and recurrent granulosa cell tumor representing an example of two independent tumors in a unique one-on-another collision.
  • [MeSH-major] Adenocarcinoma / diagnosis. Colonic Neoplasms / diagnosis. Granulosa Cell Tumor / diagnosis. Neoplasms, Multiple Primary / diagnosis. Ovarian Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ceska Gynekol. 2000 May;65(3):163-6 [10953492.001]
  • [Cites] Rom J Morphol Embryol. 2007;48(1):75-8 [17502956.001]
  • [Cites] J Clin Oncol. 2003 Mar 15;21(6):1180-9 [12637488.001]
  • [Cites] Pathol Oncol Res. 2003;9(3):188-92 [14530814.001]
  • [Cites] Cancer. 1976 Jul;38(1):335-40 [181131.001]
  • [Cites] Dis Colon Rectum. 1984 Dec;27(12):822-4 [6389052.001]
  • [Cites] Gastroenterol Clin Biol. 1990;14(2):185-6 [2328885.001]
  • [Cites] Surgery. 1993 Feb;113(2):223-6 [8430371.001]
  • [Cites] J Surg Oncol. 1994 Feb;55(2):71-7 [8121188.001]
  • [Cites] Gynecol Oncol. 1996 Mar;60(3):484-8 [8774662.001]
  • [Cites] Pathol Int. 1996 Jul;46(7):538-9 [8870012.001]
  • [Cites] Indian J Gastroenterol. 1997 Jan;16(1):28-9 [9167378.001]
  • [Cites] Arch Pathol Lab Med. 1998 Mar;122(3):262-5 [9823866.001]
  • [Cites] Surg Oncol. 2005 Jul;14(1):11-25 [15777886.001]
  • [Cites] Dig Dis Sci. 2002 Dec;47(12):2758-9 [12498297.001]
  • (PMID = 17949502.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2164962
  •  go-up   go-down


92. McKenna PB, Mulcahy E, Waldron D: Early onset of colonic adenocarcinoma associated with cystic fibrosis--a case report. Ir Med J; 2006 Nov-Dec;99(10):310-1
MedlinePlus Health Information. consumer health - Cystic Fibrosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Early onset of colonic adenocarcinoma associated with cystic fibrosis--a case report.
  • We report the case of the onset of colorectal adenocarcinoma occurring in an 18 year-old patient, suffering from Cystic Fibrosis.
  • This represents a presentation of colon cancer at an earlier stage than previously reported.
  • [MeSH-major] Adenocarcinoma / etiology. Colorectal Neoplasms / etiology. Cystic Fibrosis / complications


93. Schade VL, Roukis TS, Haque M: Clostridium septicum necrotizing fasciitis of the forefoot secondary to adenocarcinoma of the colon: Case report and review of the literature. J Foot Ankle Surg; 2010 Mar-Apr;49(2):159.e1-8
MedlinePlus Health Information. consumer health - Foot Injuries and Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clostridium septicum necrotizing fasciitis of the forefoot secondary to adenocarcinoma of the colon: Case report and review of the literature.
  • C septicum infections are most often nontraumatic in nature and associated with either an occult colonic or hematologic malignancy.
  • Presented is a case of necrotizing fasciitis of the forefoot caused by C septicum associated with an occult adenocarcinoma of the colon in a patient with uncontrolled diabetes.
  • [MeSH-major] Adenocarcinoma / complications. Clostridium Infections / complications. Clostridium septicum. Colonic Neoplasms / complications. Fasciitis, Necrotizing / complications. Foot Diseases / complications. Forefoot, Human

  • Genetic Alliance. consumer health - Necrotizing fasciitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.
  • (PMID = 19945301.001).
  • [ISSN] 1542-2224
  • [Journal-full-title] The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons
  • [ISO-abbreviation] J Foot Ankle Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


94. Imai H, Saio M, Nonaka K, Suwa T, Umemura N, Ouyang GF, Nakagawa J, Tomita H, Osada S, Sugiyama Y, Adachi Y, Takami T: Depletion of CD4+CD25+ regulatory T cells enhances interleukin-2-induced antitumor immunity in a mouse model of colon adenocarcinoma. Cancer Sci; 2007 Mar;98(3):416-23
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Depletion of CD4+CD25+ regulatory T cells enhances interleukin-2-induced antitumor immunity in a mouse model of colon adenocarcinoma.
  • IL-2-transfected mouse colon adenocarcinoma (MC38/IL-2) cells were implanted subcutaneously or intrahepatically into male C57BL/6 mice, and tumor growth and the proportion of tumor-infiltrating lymphocytes with Treg-cell depletion in response to treatment with anti-CD25 monoclonal antibody (PC61) were determined.
  • [MeSH-major] Adenocarcinoma / immunology. Colonic Neoplasms / immunology. Interleukin-2 / pharmacology. Lymphocyte Depletion. Neoplasms, Experimental / immunology. T-Lymphocytes, Regulatory / immunology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17270031.001).
  • [ISSN] 1347-9032
  • [Journal-full-title] Cancer science
  • [ISO-abbreviation] Cancer Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Interleukin-2
  •  go-up   go-down


95. Caballero Gullón L, Borrego Dorado I, Vázquez Albertino R: [A colon adenocarcinoma and a pharyngeal carcinoma incidentally detected by means of (18)F-FDG PET in a patient diagnosed of lung cancer]. Rev Esp Med Nucl; 2010 Jan-Feb;29(1):29-31
MedlinePlus Health Information. consumer health - Throat Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A colon adenocarcinoma and a pharyngeal carcinoma incidentally detected by means of (18)F-FDG PET in a patient diagnosed of lung cancer].
  • [Transliterated title] Adenocarcinoma de colon y carcinoma faríngeo detectados incidentalmente mediante (18)F-FDG PET en paciente diagnosticado de cáncer de pulmón.
  • This occurs quite often in the case of lung cancer.
  • In this sense, the positron emission tomography with (18)F-FDG (FDG-PET) is widely used for the diagnosis and treatment of cancer patients.
  • It is also especially useful in patients with solitary pulmonary nodule, bronchogenic carcinoma, head and neck cancer, colon cancer, tumors of unknown origin, lymphomas, etc.
  • We report a clinical case showing how two synchronous cancers were incidentally detected in a 73-year old patient diagnosed with lung cancer and referred for (FDG-PET) study.
  • [MeSH-major] Adenocarcinoma / radionuclide imaging. Carcinoma / radionuclide imaging. Colonic Neoplasms / radionuclide imaging. Fluorine Radioisotopes. Fluorodeoxyglucose F18. Lung Neoplasms / radiography. Neoplasms, Multiple Primary / radionuclide imaging. Pharyngeal Neoplasms / radionuclide imaging. Positron-Emission Tomography. Radiopharmaceuticals

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 Elsevier España, S.L. y SEMNIM. All rights reserved.
  • (PMID = 19969392.001).
  • [ISSN] 0212-6982
  • [Journal-full-title] Revista española de medicina nuclear
  • [ISO-abbreviation] Rev Esp Med Nucl
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Fluorine Radioisotopes; 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


96. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA; 2008 Jan 30;299(4):425-36
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.
  • CONTEXT: MicroRNAs have potential as diagnostic biomarkers and therapeutic targets in cancer.
  • No study has evaluated the association between microRNA expression patterns and colon cancer prognosis or therapeutic outcome.
  • OBJECTIVE: To identify microRNA expression patterns associated with colon adenocarcinomas, prognosis, or therapeutic outcome.
  • DESIGN, SETTING, AND PATIENTS: MicroRNA microarray expression profiling of tumors and paired nontumorous tissues was performed on a US test cohort of 84 patients with incident colon adenocarcinoma, recruited between 1993 and 2002.
  • MAIN OUTCOME MEASURES: MicroRNAs that were differentially expressed in tumors and microRNA expression patterns associated with survival using cancer-specific death as the end point.
  • In situ hybridization demonstrated miR-21 to be expressed at high levels in colonic carcinoma cells.
  • The 5-year cancer-specific survival rate was 57.5% for the Maryland cohort and was 49.5% for the Hong Kong cohort.
  • CONCLUSIONS: Expression patterns of microRNAs are systematically altered in colon adenocarcinomas.

  • COS Scholar Universe. author profiles.
  • SciCrunch. ArrayExpress: Data: Microarray .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15524-9 [12434020.001]
  • [Cites] Pharmacogenomics J. 2007 Oct;7(5):297-304 [17189960.001]
  • [Cites] Cell. 2003 Apr 4;113(1):25-36 [12679032.001]
  • [Cites] Curr Biol. 2003 Apr 29;13(9):790-5 [12725740.001]
  • [Cites] Mol Cancer Res. 2003 Oct;1(12):882-91 [14573789.001]
  • [Cites] Science. 2004 Jan 2;303(5654):83-6 [14657504.001]
  • [Cites] Cell. 2004 Jan 23;116(2):281-97 [14744438.001]
  • [Cites] J Mol Biol. 2004 May 28;339(2):327-35 [15136036.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9740-4 [15210942.001]
  • [Cites] Stat Med. 1985 Jan-Mar;4(1):87-90 [3992076.001]
  • [Cites] Cell. 1990 Jun 1;61(5):759-67 [2188735.001]
  • [Cites] Cell. 1993 Dec 3;75(5):843-54 [8252621.001]
  • [Cites] Cell. 1993 Dec 3;75(5):855-62 [8252622.001]
  • [Cites] Nature. 2005 Jun 9;435(7043):828-33 [15944707.001]
  • [Cites] Nature. 2005 Jun 9;435(7043):834-8 [15944708.001]
  • [Cites] Dis Colon Rectum. 2005 Jun;48(6):1161-8 [15868237.001]
  • [Cites] Cancer Res. 2005 Jul 15;65(14):6029-33 [16024602.001]
  • [Cites] Cancer Res. 2005 Aug 15;65(16):7065-70 [16103053.001]
  • [Cites] N Engl J Med. 2005 Oct 27;353(17):1793-801 [16251535.001]
  • [Cites] Cancer Res. 2005 Nov 1;65(21):9628-32 [16266980.001]
  • [Cites] Nature. 2005 Dec 1;438(7068):685-9 [16258535.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61 [16461460.001]
  • [Cites] Cancer Cell. 2006 Mar;9(3):189-98 [16530703.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3687-92 [16505370.001]
  • [Cites] Nat Rev Cancer. 2006 Apr;6(4):259-69 [16557279.001]
  • [Cites] Arch Med Res. 2006 May;37(4):548-51 [16624657.001]
  • [Cites] Gastroenterology. 2006 Jun;130(7):2113-29 [16762633.001]
  • [Cites] Mol Cancer. 2006;5:29 [16854228.001]
  • [Cites] Nat Genet. 2006 Sep;38(9):1060-5 [16878133.001]
  • [Cites] Nat Rev Cancer. 2006 Nov;6(11):857-66 [17060945.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18680-4 [17121985.001]
  • [Cites] Am J Respir Cell Mol Biol. 2007 Jan;36(1):8-12 [16917074.001]
  • [Cites] CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66 [17237035.001]
  • [Cites] Cancer Res. 2007 Feb 1;67(3):976-83 [17283129.001]
  • [Cites] Curr Mol Med. 2007 Feb;7(1):29-46 [17311531.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2750-5 [17293455.001]
  • [Cites] Oncogene. 2007 Apr 26;26(19):2799-803 [17072344.001]
  • [Cites] JAMA. 2007 May 2;297(17):1901-8 [17473300.001]
  • [Cites] JAMA. 2007 May 2;297(17):1923-5 [17473304.001]
  • [Cites] J Biol Chem. 2007 May 11;282(19):14328-36 [17363372.001]
  • [CommentIn] JAMA. 2008 Jun 11;299(22):2628; author reply 2628-9 [18544721.001]
  • (PMID = 18230780.001).
  • [ISSN] 1538-3598
  • [Journal-full-title] JAMA
  • [ISO-abbreviation] JAMA
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / / Z01 BC005480-22
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / MIRN21 microRNA, human; 0 / MicroRNAs; 0 / RNA, Neoplasm
  • [Other-IDs] NLM/ NIHMS82855; NLM/ PMC2614237
  •  go-up   go-down


97. Pajak B, Orzechowski A: IFN-alpha competes with TNF-alpha for STAT-1alpha; molecular basis for immune escape of human colon adenocarcinoma COLO 205 cells. Oncol Rep; 2007 Oct;18(4):1039-45
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] IFN-alpha competes with TNF-alpha for STAT-1alpha; molecular basis for immune escape of human colon adenocarcinoma COLO 205 cells.
  • The resistance of transformed colon epithelial cells to immune system-mediated extrinsic apoptosis allows the development of fast growing colon cancer.
  • Several tactics have been shown to clarify how colon adenocarcinomas avoid cell deletion and remain viable.
  • Regardless of the presence of active membrane receptors, colorectal cancer cells resist interferon-mediated cell death.
  • STAT-1alpha renders colon adenocarcinoma COLO 205 cells less susceptible to TNF-alpha-induced apoptosis but IFN-alpha further extends the immune escape.
  • [MeSH-major] Adenocarcinoma / drug therapy. Angiogenesis Inhibitors / pharmacology. Colonic Neoplasms / drug therapy. Interferon-alpha / pharmacology. STAT1 Transcription Factor / metabolism. Tumor Necrosis Factor-alpha / pharmacology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17786371.001).
  • [ISSN] 1021-335X
  • [Journal-full-title] Oncology reports
  • [ISO-abbreviation] Oncol. Rep.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Interferon-alpha; 0 / NF-kappa B; 0 / Receptors, Tumor Necrosis Factor, Type I; 0 / STAT1 Transcription Factor; 0 / STAT1 protein, human; 0 / TNF Receptor-Associated Death Domain Protein; 0 / Tumor Necrosis Factor-alpha
  •  go-up   go-down


98. Coccetta M, Covarelli P, Cirocchi R, Boselli C, Santoro A, Cacurri A, Grassi V, Barillaro I, Koltraka B, Spizzirri A, Pressi E, Trastulli S, Gullà N, Noya G, Sciannameo F: [The sentinel lymph node mapping in colon cancer]. G Chir; 2010 Nov-Dec;31(11-12):556-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The sentinel lymph node mapping in colon cancer].
  • [Transliterated title] Il linfonodo sentinella nei tumori del colon.
  • BACKGROUND: malignant tumors of the colon can metastases along the lymphatic system in a sequential way, which means that there will be a first node to be involved and then from this disease will pass to another node and so gradually.
  • The sentinel lymph node is the first lymph node or group of nodes reached by metastasizing cancer cells from a tumor.
  • OBJECTIVES: the present work aims to determine the predictive value of the sentinel lymph node procedure in the staging of non-metastatic colon cancer.
  • PATIENTS AND METHODS: in this prospective study joined up only 26 patients with adenocarcinoma of the colon T2-T3, without systemic metastases, and with these criteria for inclusion: a) minimum age: 18 years old;.
  • [MeSH-major] Colonic Neoplasms / pathology. Lymph Nodes / pathology. Lymph Nodes / surgery. Sentinel Lymph Node Biopsy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21232204.001).
  • [ISSN] 0391-9005
  • [Journal-full-title] Il Giornale di chirurgia
  • [ISO-abbreviation] G Chir
  • [Language] ita
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Coloring Agents
  •  go-up   go-down


99. Djuranovic SP, Spuran MM, Kovacevic NV, Ugljesic MB, Kecmanovic DM, Micev MT: Mucinous cystadenoma of the appendix associated with adenocarcinoma of the sigmoid colon and hepatocellular carcinoma of the liver: report of a case. World J Gastroenterol; 2006 Mar 28;12(12):1975-7
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mucinous cystadenoma of the appendix associated with adenocarcinoma of the sigmoid colon and hepatocellular carcinoma of the liver: report of a case.
  • This condition is often associated with other neoplasia, especially adenocarcinoma of the colon and ovaries.
  • He had a big cystadenoma of the appendix associated with adenocarcinoma of the colon and hepatocellular carcinoma of the liver.
  • The patient underwent right haemicolectomy, sigmoid colon resection and segmental resection of the liver.
  • [MeSH-major] Adenocarcinoma / complications. Appendiceal Neoplasms / complications. Carcinoma, Hepatocellular / complications. Cystadenoma, Mucinous / complications. Liver Neoplasms / complications. Sigmoid Neoplasms / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dis Colon Rectum. 2000 Apr;43(4):559-60 [10789759.001]
  • [Cites] Dis Colon Rectum. 2001 Jul;44(7):1034-6 [11496084.001]
  • [Cites] Curr Surg. 2003 May-Jun;60(3):341-3 [14972272.001]
  • [Cites] Cancer. 1973 Dec;32(6):1525-41 [4757938.001]
  • [Cites] Am J Gastroenterol. 1992 Jun;87(6):787-9 [1590322.001]
  • [Cites] Surg Endosc. 2003 May;17(5):833-4 [15768456.001]
  • [Cites] J Chir (Paris). 1994 Jun-Jul;131(6-7):303-12 [7844184.001]
  • [Cites] Am J Gastroenterol. 1997 May;92(5):898-9 [9149213.001]
  • [Cites] Am J Gastroenterol. 1997 Oct;92(10):1920-2 [9382067.001]
  • [Cites] Abdom Imaging. 1998 May-Jun;23(3):292-6 [9569300.001]
  • [Cites] Radiographics. 1998 Jul-Aug;18(4):1049-50 [9672990.001]
  • [Cites] AJR Am J Roentgenol. 1992 Jul;159(1):69-72 [1609724.001]
  • (PMID = 16610012.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC4087531
  •  go-up   go-down


100. Traba Villameytide ML, Orts Costa JA, Morell M: [Study of a intestinal enteroliths in human patient with colon adenocarcinoma. Is it similar to renal calculi?]. Actas Urol Esp; 2006 Feb;30(2):206-14

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Study of a intestinal enteroliths in human patient with colon adenocarcinoma. Is it similar to renal calculi?].
  • [Transliterated title] Estudio de un cálculo intestinal en un paciente con adenocarcinoma de colón. Es similar a los cálculos renales?
  • This enterolithis is associated with colon adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / complications. Calculi / chemistry. Calculi / complications. Colonic Neoplasms / complications. Intestinal Diseases / complications. Kidney Calculi / chemistry

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16700212.001).
  • [ISSN] 0210-4806
  • [Journal-full-title] Actas urologicas españolas
  • [ISO-abbreviation] Actas Urol Esp
  • [Language] spa
  • [Publication-type] Case Reports; Comparative Study; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down






Advertisement